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Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and 
attention-deficit/hyperactivity disorder (ADHD) are diagnosed in a significant minority of 
children, adolescents, and adults worldwide. Physical examinations are recommended for 
children undergoing assessment of NDDs, including evaluation of the presence of 
morphological variants, which are altered physical features of the body such as low-set 
ears, curved finger digits, narrow lips, etc. Morphological variants have been shown to 
appear more frequently in children with some NDDs, such as ASD, and in children with 
genetic syndromes. Physical examinations for morphological variants may help identify 
children undergoing assessment for NDDs who would benefit from further screening or 
testing (i.e., genetic). However, these physical examinations are often subjective, time-
consuming, and require a high level of expertise to perform.  
 
The thesis uses a cohort of twins recruited in the Roots of Autism and ADHD Twin Study 
in Sweden (RATSS) who received detailed in-person clinical and automated morphological 
assessments, neuroimaging, and molecular genetic testing. The aims of the studies in this 
thesis are to identify characteristics of morphological variants that can support NDD 
screening and risk assessment, to test whether it is possible to obtain reliable morphological 
assessments using low-cost, automated technology, and to utilize the twin design to explore 
the potential genetic and environmental influences on the development of morphological 
variants. Overall, it was hypothesized that individuals with NDDs would have increased 
numbers of morphological variants compared to those with typical development.  
 
Study I explored the presence of minor physical anomalies (MPAs) in twin pairs in RATSS 
who received in-person clinical assessments and compared MPAs found in twins with 
NDDs to those with typical development. This study found that individuals with ASD in 
particular had increased numbers of MPAs, as well as those with increasing scores on a 
measure for autistic traits and those with lower IQs. Monozygotic twins, regardless of NDD 
diagnosis, had similar numbers and types of MPAs.  
 
Study II explored the relationship of the 2nd and 4th finger digit ratio (2D:4D) in individuals 
with diagnoses of various NDDs and found a small decrease in the ratio in individuals with 
NDDs overall, but not for any particular NDD. Additionally, the study confirmed the 
 results of previous studies on 2D:4D ratios by finding lower ratios in males compared with 
females.  
 
Study III detailed the presence of morphological variants, as well as diagnostic and 
behavioral findings, in a twin pair with an identified genetic mutation (i.e., duplication on 
Chromosome 12) and NDD diagnoses of ASD and ADHD. The study compared phenotypic 
findings in this twin pair with other individuals worldwide identified with a similar size and 
location of duplication. The twin pair, along with the other individuals with the duplication, 
were reported to have learning difficulties, cognitive impairment, language and gross motor 
delays, and at least one NDD (i.e., intellectual disability, ADHD, ASD). The twin pair and 
other individuals identified were primarily males and had morphological variants present in 
head shape, forehead, eyes, vision, ears, nose, oral-facial region, and toe digits.  
 
Finally, Study IV compared in-person clinical assessments of facial morphological variants 
(FMVs) with automated assessments using Face2Gene (F2G), and described findings from 
the automated assessments in a large sample of twins with either typical development or 
NDDs. The study also explored differences in FMVs by presence of NDD diagnosis. The 
study found high to nearly complete agreement between clinical and automated assessments 
of FMVs. However, FMVs were neither increased, nor distinguishable, between individuals 
with NDD diagnoses versus those with typical development.  
 
The studies in this thesis point to the potential value of morphological assessment as part of 
the physical examination in individuals with NDDs, particularly for those who may have 
NDDs such as ASD, increased autistic traits, lower IQs, or genetic variants. In general, the 
studies in this thesis found increased numbers of morphological variants in individuals with 
NDDs and in some with genetic variations (i.e., 12q12 duplication), but significant 
differences in the number of variants in individuals diagnosed with NDDs versus typical 
development were not always identified. Although automated assessments are now 
available to detect morphological variants, they are limited to just certain body regions (i.e., 
face). In contrast, in-person clinical assessments allow for a full, head-to-toe examination 
and appear to be better at identifying individuals with morphological variants. In 
conclusion, identification of morphological variants may point to individuals with possible 
NDDs or underlying genetic alterations and have the potential to help determine individuals 
undergoing diagnosis for NDDs who would most benefit from further screening or testing, 
such as genetic testing.   
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1 INTRODUCTION 
1.1 NEURODEVELOPMENTAL DISORDERS (NDDS) 
The umbrella concept of neurodevelopmental disorders (NDDs) includes various types of 
conditions that emerge in early childhood and cause mostly persistent impairment in 
cognitive, social, academic, and/or occupational functioning. NDDs include autism 
spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual 
disability (ID), communication disorders, specific learning disorders, and motor disorders. 
There is substantial overlap among the various NDDs, along with a sex ratio that is skewed 
towards males with most of the disorders [American Psychiatric Association (APA), 2013]. 
Although no estimates exist regarding the prevalence of NDDs as an overarching diagnostic 
category, Boyle et al. (2011) examined developmental disabilities (including learning 
disabilities, ASD, ADHD, and other developmental delays) in a sample of children from the 
United States (US) ages three to 17 years and found a prevalence of nearly 14%. Earlier 
detection of NDDs is critical as it allows the opportunity for early intervention (Sand et al., 
2005; Sices, Feudtner, McLaughlin, Drotar, & Williams, 2004). Early intervention has been 
shown to dampen the effects of a delay from NDDs on a child’s development and enhance 
the child and family’s well-being (Council on Children With Disabilities, 2006; Sand et al., 
2005).  
 
Despite efforts to identify NDDs early, multiple studies suggest that the time between 
parents first noticing concerns about their child’s development to receiving a diagnosis of a 
NDD can be quite prolonged (Fridman, Banaschewski, Sikirica, Quintero, & Chen, 2017; 
Miodovnik, Harstad, Sideridis, & Huntington, 2015; Zuckerman, Lindly, & Sinche, 2015). 
Various behavioral screening measures exist to detect some NDDs like ASD early (Lord, 
Elsabbagh, Baird, & Veenstra-Vanderweele, 2018). However, these measures are not 
always consistently used by health care providers (Constantino & Charman, 2016; Radecki, 
Sand-Loud, O'Connor, Sharp, & Olson, 2011; Sand et al., 2005), often due to issues 
including lack of training on use of instruments, where to refer children (King et al., 2010; 
Morelli et al., 2014), or the instruments do not perform well in correctly identifying young 
children at risk (Haglund, Dahlgren, Gustafsson, Råstam, & Källen, 2017).  
 
A variety of biomarkers are being explored as possible ways to detect NDDs earlier or 
place individuals with NDDs into subgroups, which may help determine individuals who 
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would benefit most from different types of assessments or treatment or also help identify 
unique genes or brain mechanisms that underlie these disorders. Some examples of 
biological samples being explored as biomarkers include blood, teeth, cerebral spinal fluid, 
stool, and variations in physical appearance, or what are known as morphological variants 
(Bölte et al., 2014; Goldani, Downs, Widjaja, Lawton, & Hendren, 2014; Ruggeri, Sarkans, 
Schumann, & Persico, 2014). For morphological variants in particular, the examination of 
these variants has evolved through time with newer automated methods now available that 
may have the potential to assess variants effectively and objectively in individuals with 
NDDs.  
1.2 AUTISM SPECTRUM DISORDER (ASD) 
ASD is a complex neurodevelopmental disorder behaviorally characterized by impairments 
in social communication and interactions and the presence of repetitive, stereotyped 
behaviors (APA, 2013). Recent studies have shown high heritability of ASD, with 
estimates between 56-95% (Bai et al., 2019; Colvert et al., 2015; Ronald & Hoekstra, 2011; 
Sandin et al., 2017; Tick, Bolton, Happe, Rutter, & Rijsdijk, 2016). A report from the 
Centers for Disease Control and Prevention estimates the prevalence of ASD in children in 
the United States to be one in 59 children, or around 1.6% (Baio et al., 2018). A recent 
study from Stockholm County in Sweden shows an ASD prevalence of about 1.4% in 
children (0-12 years) and 3.1% in adolescents (13-17 years) (Kosidou, Edwin, Magnusson, 
& Dalman, 2017). A large majority of individuals with ASD have comorbid conditions, 
including other neurodevelopmental issues such as ADHD or ID; medical issues such as 
seizure or sleep disorders; and psychiatric and psychological issues such as anxiety or 
depression (Lai, Lombardo, & Baron-Cohen, 2014; Leyfer et al., 2006; Lord et al., 2018; 
Simonoff et al., 2008).  
 
ASD is typically diagnosed with data obtained from multiple informants (e.g., parents or 
other caregivers, teachers, etc.) based on criteria set forth by the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5; APA, 2013) and ICD-10 (World Health 
Organization, 1992) and includes the aforementioned impairments in social communication 
and interaction and restricted and repetitive behaviors, interests, or activities. These issues 
present in early childhood and affect everyday functioning (APA, 2013). Recommendations 
exist to screen for ASD in the primary care setting beginning as early as 18 months of age 
(Johnson, Myers, & American Academy of Pediatrics Council on Children With 
Disabilities, 2007; Zwaigenbaum et al., 2015) and it is generally thought ASD can be 
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diagnosed reliably in children as young as two years of age (Constantino & Charman, 2016; 
Lai et al., 2014; Tonge, Bull, Brereton, & Wilson, 2014), although a recent study suggested 
ASD may be reliably diagnosed in children as young as 14 months of age (Pierce et al., 
2019). However, it is important to assess the validity of diagnostic instruments for young 
children, as was done in Zander, Sturm, and Bölte (2015), which recommends the 
combined use of the Autism Diagnostic Interview-Revised (ADI-R; Rutter, LeCouteur, & 
Lord, 2003) and the Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2012) 
for young children suspected to have ASD. Even with the ability to screen for and 
potentially diagnose ASD early, research shows children often receive a diagnosis later in 
childhood (Zuckerman et al., 2015). Children who receive timely diagnosis of ASD have 
the opportunity to receive early intervention with the potential to result in improved long-
term outcomes for the child and family (Zwaigenbaum et al., 2015). Although no cure 
exists for ASD, a variety of behavioral interventions and medications have been explored 
for the treatment of symptoms associated with the disorder. However, the recommended 
interventions or treatments vary by individual due to the heterogeneity of the disorder, and 
research in this area is ongoing (Lai et al., 2014; Sahin & Sur, 2015; Tonge et al., 2014). 
1.3 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) 
ADHD is a NDD arising in early to middle childhood and is behaviorally characterized by 
inattention and hyperactivity/impulsivity that interfere with quality of life or functioning 
(APA, 2013). Heritability estimates for ADHD are around 70-80% (Brikell, Kuja-Halkola, 
& Larsson, 2015). It is estimated that about 5.3-7.2% of children exhibit ADHD worldwide 
(Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007; Thomas, Sanders, Doust, Beller, 
& Glasziou, 2015) and 2.0% of children (0-12 years) and 7.7% of adolescents (13-17 years) 
in Stockholm County, Sweden (Kosidou et al., 2017). Co-morbidity is also high in ADHD, 
with other co-occurring disorders including ASD, communication disorders, ID, and 
behavioral problems like conduct disorder and oppositional defiant disorder (as reviewed in 
Thapar & Cooper, 2016). Studies point to poor outcomes for individuals with a diagnosis of 
ADHD (Thapar & Cooper, 2016). For example, a study examining males diagnosed during 
childhood with ADHD found worse educational, economical, occupational, and social 
outcomes in adulthood compared with males without a diagnosis (Klein et al., 2012). 
 
ADHD diagnosis is based on the ICD-10 definition of a hyperkinetic disorder or on criteria 
set forth in the DSM-5, which includes the child having experienced issues with inattention 
and/or hyperactivity and impulsivity, along with the presence of these issues before the age 
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of 12 years and in multiple settings. Additionally, the disorder must interfere with 
functioning and the symptoms must not be the result of another disorder or psychotic 
issues. ADHD is diagnosed through multiple methods with the use of multiple informants 
(APA, 2013; National Institute for and Care Excellence, 2018). Treatment guidelines for 
ADHD include those developed by the National Institute for Health and Care Excellence 
(NICE, 2018). The treatment guidelines are based on the child’s age and recommendations 
include behavioral interventions like parent-training programs and environmental 
modifications (e.g., change in lighting or noise levels, reducing distractions) to help 
decrease issues for individuals with ADHD. For children over the age of five years, the use 
of stimulant medication (e.g., methylphenidate as first line agent) may be considered. 
Cognitive behavioral therapy may also be recommended for children who experience some 
improvement with medication, but still have problematic symptoms (NICE, 2018). 
1.4 OTHER NDD 
Other NDD is a phrase used in the DSM-5 to include ID, communication disorders, specific 
learning disorders, and motor disorders (APA, 2013). Key features of these disorders are 
that they often arise in childhood and tend to persist into adulthood (Thapar, Cooper, & 
Rutter, 2017). Similar to ASD and ADHD, disorders in other NDD are believed to be 
highly heritable with a high level of overlap (Thapar et al., 2017). ID is thought to affect 
around one percent of individuals worldwide. It is diagnosed through clinical testing with 
behavioral measures and standardized intelligence testing (APA, 2013; Maulik, 
Mascarenhas, Mathers, Dua, & Saxena, 2011). Communication disorders include issues 
with both expressive and receptive language abilities, including speech sound disorder, 
childhood-onset fluency disorder, and social communication disorder. For these disorders, 
diagnosis is based on the presence of communication difficulties that have an onset in early 
childhood and are not attributable to other disorders or medical issues (APA, 2013). 
Learning disorders include challenges related to learning in the areas of reading, math, or 
written expression. The issues may first present in early childhood or become noticeable 
when the child is older and more academic demands are placed on the child (APA, 2013). It 
is estimated around 7% of children have learning disorders (Boyle et al., 2011). Motor 
disorders involve issues with coordination and movement, including vocal and motor tics. 
Diagnosis is based on issues with motor ability that begin in early childhood and are not 
attributable to other disorders or medical issues (APA, 2013). 
  5 
1.5 ETIOLOGY OF NDDS 
1.5.1 Genetics of NDDs 
 
Research into the area of genetics of NDDs is ongoing, particularly in NDDs like ASD and 
ADHD. As previously noted, heritability estimates for both disorders are high (Bai et al., 
2019; Brikell et al., 2015; Colvert et al., 2015; Ronald & Hoekstra, 2011; Sandin et al., 
2017; Tick et al., 2016). Genetic testing with chromosomal microarray analysis (CMA) to 
detect copy number variants (CNVs) is recommended as a first-tier evaluation for all 
children undergoing diagnosis of ASD and ID (Moeschler, Shevell, & Committee On 
Genetics, 2014; Schaefer, Mendelsohn, & Professional Practice and Guidelines Committee, 
2013). Genetic testing is also recommended for individuals with developmental disabilities 
broadly (Miller et al., 2010). Further genetic testing may be performed based on family 
history, findings on clinical exam that are concerning for a genetic disorder (e.g., 
morphological variants), or co-morbid medical conditions which may suggest the presence 
of a genetic disorder (Moeschler et al., 2014; Schaefer et al., 2013). 
 
Rare genetic variants with clinical significance are estimated to be present in about 16-30% 
of children with the ASD (Buxbaum, 2009; Tammimies et al., 2015), including CNVs (Lai 
et al., 2014; Levy et al., 2011; Lord et al., 2018; Lyall et al., 2017; Vorstman et al., 2017; 
Woodbury-Smith & Scherer, 2018). It is less clear what percentage of children with ADHD 
have identifiable high-risk rare genetic variants; however, many common variants are 
thought to be at play in the development of ADHD (Faraone & Larsson, 2018; Thapar & 
Cooper, 2016). Although genetic liability appears to be high for both disorders, it is 
generally believed that most cases are due to complex interactions between an individual’s 
genes and their environment (Hallmayer et al., 2011; Lai et al., 2014; Lord et al., 2018; 
Sahin & Sur, 2015). For example, De Rubeis and Buxbaum (2015) present a genotype-
phenotype model for ASD demonstrating familial risk for the disorder (e.g., heritable 
common and rare genetic variants), combined with high-risk events (e.g., de novo 
mutations) and non-genetic factors (e.g., parental age), that may place an individual over 
the threshold and result in the clinical manifestation of NDDs like ASD.  
 
A study by De Rubeis and Buxbaum (2015) notes that between 600-1200 different genes 
may be involved in ASD. As previously noted, CNVs include duplications and deletions in 
the genome and can result in either excess or loss of genetic material, respectively. The 
location of the CNV may affect either the genes produced and/or how they are expressed 
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(Merikangas, Corvin, & Gallagher, 2009; Velinov, 2019). CNVs can be either 
inherited/familial or de novo (i.e., new) and can provide great insight into the etiology of 
disease phenotypes. Chromosomal loci with CNVs are well-documented in ASD (e.g., 
deletions in 15q11-15q13, 16p11.2, and 22q11.2) and some loci have also been identified in 
ADHD (e.g., duplications at 15q13.3 and 16p13.1)(Fernandez & Scherer, 2017; Vorstman 
et al., 2017; Williams et al., 2012; Williams et al., 2010; Woodbury-Smith & Scherer, 
2018). However, De Rubeis and Buxbaum (2015) note that the identified effect of the 
mutations spanning the different genes is highly variable for the resulting phenotype. For 
example, De Rubeis and Buxbaum discuss well-known CNVs (i.e., 22q11.2 and 16p11.2 
deletions) in which individuals with these deletions typically have ASD, although there are 
cases with these deletions who also have typical development. Affected genes in the area of 
CNVs (e.g., SHANK3, NLGN4X, NRXN1, MAPK3, CHD2, CHD8, ANK2, etc.) have been 
studied in order to explore potential etiological origins of NDDs (Coe et al., 2019; De 
Rubeis & Buxbaum, 2015; Fernandez & Scherer, 2017; Velinov, 2019; Vorstman et al., 
2017; Woodbury-Smith & Scherer, 2018) and new discoveries are likely to continue 
through research in this area.  
1.5.2 Environmental Risks for NDDs 
A variety of environmental factors have been explored in connection with the development 
of ASD, including preconception risk factors (e.g., parental age), prenatal risk factors (e.g., 
exposure to medications like valproate or selective serotonin reuptake inhibitors; toxic 
chemicals; maternal immune activation), perinatal and postnatal risks (e.g., birth 
complications, preterm birth), as well as protective factors (e.g., prenatal folic acid 
supplementation)(Bölte, Girdler, & Marschik, 2018; Lord et al., 2018; Lyall et al., 2017; 
Mandy & Lai, 2016). Possible environmental factors for ADHD include prematurity, low 
birth weight, maternal smoking, and exposure to environmental toxins (Gustafsson & 
Kallen, 2011; Thapar & Cooper, 2016). As previously noted, it is believed that NDDs result 
from the interactions between an individual’s genes and environmental risk factors (De 
Rubeis & Buxbaum, 2015; Hallmayer et al., 2011; Lai et al., 2014; Lord et al., 2018; Sahin 
& Sur, 2015). 
1.6 TWIN STUDIES 
There are several types of twin study designs that are available for research, including the 
classic twin design, the co-twin control design, and the matched case-control design. In 
general, twin designs are based on the fact that monozygotic (MZ) twins share nearly 100% 
of their genomes, while dizygotic (DZ) twins share approximately 50% of their genomes. 
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This distinction allows researchers to compare outcomes or characteristics in MZ with DZ 
twins to explore the possible contribution of genes or environment in their research 
questions. For example, greater similarity on an outcome for MZ versus DZ twins may 
indicate strong genetic influence (Martin, Boomsma, & Machin, 1997; Posthuma & 
Polderman, 2013).  
 
For twin studies, two assumptions are generally made: 1) equal environment and 2) random 
assortative mating. Equal environment refers to the assumption that if twins, regardless of 
zygosity, are raised in the same home, no difference exists in the effect of the environment 
on MZ versus DZ twin pairs. A violation of equal environments may result in issues 
regarding estimates of heritability. Assortative mating refers to the assumption that there is 
random selection of partners for the parents of these twins (Sahu & Prasuna, 2016; 
Willfors, Tammimies, & Bölte, 2017). A violation of the assortative mating assumption 
might mean parents mate with individuals more phenotypically similar to themselves and 
may lead to DZ twins, in particular, who share more than 50% of their genomes (Sahu & 
Prasuna, 2016; Willfors et al., 2017). 
 
Twin studies have several strengths and limitations. A strength is that most twins share a 
similar prenatal environment and some level of similarity in their upbringing if reared 
together. Regardless of zygosity, twins are also the same age and generally have the same 
parents (although it is possible for DZ twins to have separate fathers). These strengths are 
in contrast to sibling studies with offspring who are different ages and subsequently have 
different prenatal and postnatal environments and are more likely than twins to have 
different fathers. Additionally, twin studies can save both time and cost as they are 
generally less challenging than traditional case-control studies where one needs to find a 
matched control. Limitations to twin studies, however, center on whether or not being a 
twin places an individual at an increased risk for certain outcomes, and if results from twin 
studies can be generalized to non-twin populations (Martin et al., 1997; Sahu & Prasuna, 
2016).  
1.6.1 Twin Studies in NDDs 
Several twin studies have been conducted in the area of NDDs, primarily ASD or ADHD 
(Bailey et al., 1995; Freitag & Retz, 2010; Ghirardi et al., 2018; Monterrey et al., 2017; 
Posthuma & Polderman, 2013; Ronald, Simonoff, Kuntsi, Asherson, & Plomin, 2008; Tick 
et al., 2016) due to their unique ability to explore genetic and environmental factors 
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influencing phenomena of interest. However, twin studies focusing on exploring NDDs as 
an overarching diagnostic entity altogether are more limited (Bölte et al., 2014; Posthuma 
& Polderman, 2013). Although some previous studies have identified twinning as a risk 
factor for ASD in particular (Betancur, Leboyer, & Gillberg, 2002; Greenberg, Hodge, 
Sowinski, & Nicoll, 2001), more recent studies have not found similar conclusions when 
comparing the rate of ASD diagnosis or traits in twins with those of singletons or in non-
twins sibling studies (Curran et al., 2011; Hallmayer et al., 2002).  
 
The twin studies in the Roots of Autism and ADHD Twin Study Sweden (RATSS) are 
generally based on both the co-twin control design (also known as discordant MZ pair 
design or within-twin pair differences design) and the matched case-control design. In the 
co-twin control design, MZ twins discordant for an outcome of interest are especially 
informative as there may be something unique that occurred for one twin and not the other 
that could have contributed or resulted in the outcome. In the matched case-control design, 
twins are matched on a variety of factors (e.g., age, socio-economic environment, other 
shared environment, etc.) and although this design is similar to a typical case-control design 
with unrelated individuals, it is less time-consuming and costly (Sahu & Prasuna, 2016; 
Twin Research Australia, n.d.; Willfors et al., 2017).  
 
1.7 PHYSICAL FEATURES AS A BIOMARKER OF NDDs 
Best practice guidelines recommend children undergoing diagnosis of NDDs like ASD and 
ADHD should receive a comprehensive physical examination, which, at least for ASD, was 
explicitly recommended to include an assessment for morphological variants (Johnson et 
al., 2007, NICE, 2018). Although Leo Kanner’s classic paper on children with autism 
(1943) described the children as ”essentially normal” (p. 248) in physical appearance, he 
identified a few altered physical features and medical issues in the children (i.e., large 
heads, some motor problems, and a few other specific medical issues with one of the 
children). Since Kanner’s original description of physical features in children with ASD, 
researchers in the area of NDDs have had interest in morphological variants. 
 
For some disorders with a genetic basis, an individual may present with characteristic 
physical features that aid in early detection and diagnosis of the disorder. A classic example 
is the characteristic facial features that are present in nearly all individuals with Down 
syndrome such as epicanthal folds and upslanted palpebral fissures (Ostermaier, 2019; 
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Starbuck, Reeves, & Richtsmeier, 2011). Therefore, identification of physical features that 
vary in individuals with NDDs compared to those with typical development (TD) could 
serve as a tool for early detection of individuals at risk for NDDs (Ruggeri et al., 2014). 
Consequently, a handful of researchers have explored the use of morphology, or the study 
of physical features, as a noninvasive method of early detection, as well as subgrouping of 
individuals with NDDs, particularly in ASD and ADHD (Angkustsiri et al., 2011; Miles et 
al., 2008; Minahim & Rohde, 2015; Ozgen, Hellemann, de Jonge, Beemer, & van 
Engeland, 2013; Ozgen et al., 2011). These studies have primarily relied on the use of time-
consuming and subjective physical examinations. Facial readers and other automated forms 
of assessment have become available in recent years that may help quickly and accurately 
assess morphological features in individual, although research in this area is emerging 
(Aldridge et al., 2011; Gilani et al., 2015; Lumaka et al., 2017; Obafemi-Ajayi et al., 2015; 
Tripi et al., 2019; Vorravanpreecha, Lertboonnum, Rodjanadit, Sriplienchan, & 
Rojnueangnit, 2018).  
 
1.8 MORPHOLOGICAL VARIANTS 
1.8.1 Definition 
Morphological variant is the phrase used in this thesis to describe physical features that are 
variations on those found generally in a population. Examples of morphological variants 
include low-set ears, deeply-set eyes, highly arched eyebrows, narrow nasal tip, and 
triangular face. Morphological variants often are described as “physical anomalies”, 
“phenotypic abnormalities”, or “dysmorphology” in the research literature. Although these 
terms are still extensively used in clinical practice and the literature, some view them as 
having a negative connotation since many morphological variants are actually quite 
common in the general population (Kong, 2019; Merks et al., 2006). Therefore, these 
variants may not be as “abnormal” as these some of the terms suggest, but rather alterations 
within a normal range, distal from disease. Although this thesis will generally describe 
morphological variants, terms like “dysmorphology” and “physical anomalies” will also be 
used to describe findings from other studies as these terms are still prevalent today in the 
literature.  
 
Perhaps the most informative work on describing and defining the types of morphological 
variants comes from Jon Aase (Aase, 1990), Bryan Hall (Hall, 1993), Merks, van 
Karnebeek, Caron, and Hennekam (2003), and Judith Miles (2000, 2008). Using these 
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classic references, an illustration depicting the delineation of morphological variants as 
described in this thesis is presented in Figure 1.  
 
 
Figure 1. Delineation of morphological variants. Figure modified from Merks et al. (2003).  
 
Morphological variants (what Merks and colleagues described as “phenotypic 
abnormalities”) are divided into minor variants and abnormalities. Minor variants are 
further divided by factors related to both prevalence and implications of the variants, as was 
done in Merks et al. (2003) and include 1) common variants and 2) minor anomalies. 
Common variants are present in greater than 4% of the population, are considered normal 
variants, and include features like the curve of the fifth finger digit (i.e., clinodactyly), a 
gap between the first and second toes (i.e., sandal gap), sparse eyebrows, or a broad nose tip 
(Figure 2). Minor anomalies are generally now referenced in the literature as minor 
physical anomalies or MPAs (Miles, 2008). MPAs are rare and present in less than 4% of 
the population. They possibly indicate the presence of a major malformation or some type 
of disturbance in early development (Merks et al., 2003; Miles, 2008). MPAs are subtle 
physical features, like short palpebral fissures, a single, transverse palmar crease in the 
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Figure 2. Images of minor variants and MPAs: clinodactyly (A); sandal gap (B); sparse 
eyebrows (C); broad nose tip (D); short palpebral fissures (E); single, transverse palmar 
crease (F); and long toes/arachnodactyly (G). Images courtesy of the National Human 
Genome Research Institute (genome.gov).  
 
Abnormalities are another type of morphological variant and are defined to include either a 
1) malformation (resulting from an issue during embryogenesis like a heart defect or facial 
cleft) or 2) other abnormality, like a deformity, disruption, dysplasia, or secondary 
abnormality. Hall (1993) and Merks et al. (2003) defined deformity as a normal fetal 
structure put into an abnormal position; disruption as a once normal structure altered more 
severely; dysplasia as an alteration in the development or functioning of a tissue; and 
secondary abnormality as an abnormality due to deficits in other structures. Of all the 
morphological variants in the area of NDDs, the variant that has received the most attention 
in research to date is MPAs, in part because of their potential association to either major 
malformations or disturbances in early development (Merks et al., 2003; Miles, 2008). 
 
Miles and Hillman (2000) originally developed an often-cited classification system that 
indicates the level of dysmorphology based on total number of morphological variants, 
including 1) MPAs, 2) measurement abnormalities (e.g., macrocepahly, which indicates a 
head size two standard deviations from the mean), 3) descriptive traits (similar to common 
variants in that they occur in greater than 4% of the population, but can be also be familial), 
and 4) malformations. Miles and colleagues went on to suggest individuals with six or more 
MPAs or microcephaly be classified as dysmorphic, three to five MPAs as equivocal, and 
fewer than three MPAs as non-dysmorphic (Miles & Hillman, 2000; Miles et al., 2005; 
Miles et al., 2008). Miles et al. (2005) extended the original classification of dysmorphism 
to characterize individuals with six or more morphological variants as having “complex 
autism”, which Miles et al. argued provides evidence of abnormal embryological 
development. Miles et al. also suggested that this group with “complex autism” may 
represent individuals with a genetic syndrome resulting in ASD. Individuals with what 
Miles et al. termed “essential autism” had either few, if any morphological variants, or 
lacked microcephaly, which resulted in them being classified as “non-dysmorphic.” Miles 
et al. thought individuals with “essential autism” had a more heritable cause to ASD, rather 
than a genetic syndrome like those with complex autism. Miles et al. suggested that this 
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separation of the child with ASD into “complex” and “essential” groups might help with 
determining the child’s prognosis and aid in counseling the family, especially if a genetic 
etiology to ASD is suspected.  
 
Morphological variants are named according to the Human Phenotype Ontology (HPO), 
which includes standardized terms for nearly 13,000 morphological variants (Köhler et al., 
2019). These terms are derived from the medical literature, along with genetic and rare 
disease resources (e.g., OMIM, DECIPHER, and Orphanet), and each term is used to 
identify a particular phenotypic feature (Köhler et al., 2019). HPO terms can be general 
(e.g., abnormality of the nasal tip) or very specific (e.g., narrow nasal tip) and each have a 
unique identification number (e.g., abnormality of the nasal tip=436; narrow nasal 
tip=11832). 
1.8.2 Etiology of Morphological Variants 
During early embryogenesis, the brain and skin are derived from the same neuroectodermal 
layer; therefore, morphological variants may mirror abnormal brain development since both 
systems are developing simultaneously and molecular signals determining the growth and 
development of one system may affect the other (Jones, 2013; Marcucio, Hallgrimsson, & 
Young, 2015). It is thought that morphological variants, and MPAs in particular, could 
suggest the possibility of an underlying genetic and/or environmental perturbation that 
affected early embryogenesis and led to both the variants and abnormal brain development, 
resulting in NDDs like ASD and ADHD (Accardo, Tomazic, Morrow, Haake, & Whitman, 
1991; Angkustsiri et al., 2011; Dawson, Glasson, Dixon, & Bower, 2009; Gualtieri, Adams, 
Shen, & Loiselle, 1982; Jones, 2013; Manouilenko, Eriksson, Humble, & Bejerot, 2014; 
Miller et al., 2005; Minahim & Rohde, 2015; Ozgen, Hop, Hox, Beemer, & van Engeland, 
2010; Ploeger, Raijmakers, van der Maas, & Galis, 2010; Timonen-Soivio et al., 2015).  
 
Classic studies on morphological variants have shown that the presence of multiple MPAs 
may place an individual at an increased risk of a major malformation (Leppig, Werler, 
Cann, Cook, & Holmes, 1987; Marden, Smith, & McDonald, 1964), which is defined as a 
defect that has “surgical, medical, or cosmetic importance” (Leppig et al., 1987, p. 531). 
Additionally, past research has shown morphological variants like MPAs are stable over 
time (Quinn, Renfield, Burg, & Rapoport, 1977), although some variants can be acquired 
postnatally due to some type of acute or chronic event, including birth trauma or metabolic 
disorders, both of which may result in acquired morphological variants (Hall, 1993). 
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Additionally, in terms of the long-term implications of morphological variants, one study 
was identified that positively correlated the presence of MPAs identified during childhood 
with diagnoses of psychiatric disorders (e.g., anxiety and depression) and symptoms of 
paranoia in adulthood (Cheng, Chang, Chang, Lee, & Tzang, 2014).   
 
Little is known about the heritability of morphological variants (Compton, Chan, Walker, & 
Buckley, 2011), although some studies have demonstrated higher amounts of 
morphological variants in siblings of individuals affected with neurodevelopmental or 
neuropsychiatric disorders compared with unrelated, TD controls (Dawson et al., 2009; 
Ismail, Cantor-Graae, & McNeil, 2000). However, a classic study of Canadian children 
with diagnoses of ASD or developmental delays and their TD siblings, along with matched 
TD controls, found mostly no difference in the types of MPAs in the sibling groups 
compared with controls (Rodier, Bryson, & Welch, 1997), but several significant 
differences in MPAs between those diagnosed with ASD or developmental delay and their 
siblings or controls.  
 
Studies have also explored the relationship between MPAs and prenatal or perinatal 
complications. Quinn and Rapoport (1974) found increased counts of MPAs in children of 
mothers who reported issues like bleeding or toxemia (i.e., pre-eclampsia) during 
pregnancy, as well as babies born premature, small for gestational age, or through Cesarean 
section. In later studies (Firestone & Prabhu, 1983; Links, Stockwell, Abichandani, & 
Simeon, 1980) and a review (Firestone & Peters, 1983), researchers concluded that there 
was a relationship between increased MPAs and prenatal and perinatal complications. In a 
follow-up study by Links (1980), increased maternal age was also correlated with higher 
MPA scores, citing the potential for more genetic alterations occurring in offspring of older 
mothers (e.g., child with Down Syndrome). Finally, a few studies have suggested potential 
timing for the development of morphological variants during pregnancy, with some 
suggesting their development during the first trimester (Links et al., 1980; Timonen-Soivio 
et al., 2015), while another suggests timing after the first trimester (Tripi et al., 2008). 
1.8.3 Prevalence of Morphological Variants 
Morphological variants, especially MPAs, are common and can be present in individuals 
without any accompanying diagnosis or disorder. A classic study by Marden et al. (1964) 
found a prevalence of at least one MPA in about 14% of the study’s healthy infant sample. 
Later studies also explored rates of variants in TD samples. Ulovec et al. (2004) found an 
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average of 1.70 variants (range of 0-5) in nearly 250 TD European school children using an 
18-item dysmorphology scale (i.e., Waldrop). Merks et al. (2006) explored morphological 
variants in a sample of school-age children (8-14 years) recruited from a specific 
geographical region in the Netherlands (i.e., Kennemerland region) in mid-sized city and 
smaller, surrounding towns. The study included a clinical assessment performed by a 
physician trained in morphology and a clinical geneticist on a sample of nearly 1000 school 
children. Merks et al. identified an extensive list of head to toe morphological variants in 
the school-aged children ranging in prevalence from 0% (e.g., facial cleft, coloboma, 
protruding tongue, etc.) to just over 25% (e.g., sandal gap). Subsequent studies conducted 
in the Netherlands by Ozgen and colleagues examined 683 morphological variants in 
children with ASD and in TD controls and found that in one study (2013), more than 200 
controls had an average of 9.5 morphological variants (range 2-26), 0.3 major abnormalities 
(range 0-2), 5.7 MPAs (range 2-13), and 3.2 common variants (range 0-10). In a previous 
study by Ozgen and colleagues (2011), nearly 60% of controls had at least one or more 
MPAs, while 25% had two or more MPAs. The areas with the highest frequency of MPAs 
for the controls in the Ozgen et al. (2011) study were joints (hypermobility in 9.3%), mouth 
(high palate in 7.6%), and the eyes (deep-set in 4%).  
1.8.4 Measurement/Assessment of Morphological Variants 
In many of the studies on morphological variants to date, including some classic studies, 
(Accardo et al., 1991; Bailey et al., 1995; Gualtieri et al., 1982; Manouilenko et al., 2014; 
Minahim & Rohde, 2015; Tripi et al., 2008; Ulovec et al., 2004; Waldrop & Goering, 
1971), morphological variants, primarily MPAs, were assessed through either the original 
or modified dysmorphology scale known as the Waldrop Scale (Waldrop, Pedersen, & Bell, 
1968). The scale was reported to be first developed by Goldfarb and Botstein (1956). These 
researchers used the scale in a study to evaluate physical features in children with 
schizophrenia, though the scale actually included MPAs noted in children with Down 
syndrome (Waldrop et al., 1968). Scores on the original scale ranged from 0-18 (or 0-30 if 
weighted). Items on the original scale include assessments for hair whorls, epicanthus, 
hypertelorism, adherent ear lobes, low seated, malformed, asymmetrical, soft and pliable 
ears, high palate, fifth finger curvature, single transverse palmar crease, longer index finger 
than middle finger, longer third toe compared with second toe, partial syndactylia of the 
two middle toes, gap between the first and second toe, and what was originally described at 
the time as electric hair (Waldrop et al., 1968). In a later study using the scale (Accardo et 
al., 1991), the researchers determined individuals with MPA scores less than three to five 
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on the Waldrop scale were considered to fall in the category classified as normal in 
morphological appearance, while those with scores greater than five were abnormal in 
morphological appearance.  
 
A more recently developed scale, the Autism Dysmorphology Measure (Miles et al., 2008), 
has been used in only a handful of other studies to date (e.g., Angkustsiri et al., 2011; Flor, 
Bellando, Lopez, & Shui, 2017; Spencer, Takahashi, Chakraborty, Miles, & Shyu, 2018; 
Zachariah, Oommen, Padankatti, Grace, & Glory, 2017). In contrast to the Waldrop Scale, 
the Autism Dysmorphology Measure was specifically developed from variants found on 
physical examinations of children with ASD (Miles et al., 2008). The scale consists of 12 
body areas that are evaluated to arrive at a designation of either dysmorphic or non-
dysmorphic. The ADM demonstrates good reliability and validity and the measure is 
reported to be appropriate for use by health care providers with little training in 
dysmorphology (Miles et al., 2008).  
 
Other studies have used a combination of scales (including the Waldrop) and/or checklists 
developed by the study researchers without previous validation to examine morphological 
variants in order to create an overall score based on the count of total variants present for 
analysis (Miles & Hillman, 2000; Ozgen et al., 2011; Rodier et al., 1997; Tammimies et al., 
2015; Tripi et al., 2008; Wong, Fung, & Wong, 2014). Some researchers have also used 
Magnetic Resonance Imaging (MRI) scans to measure things such as interorbital or 
interlens distances on faces of participants (Cheung et al., 2011; Hardan, Keshavan, 
Sreedhar, Vemulapalli, & Minshew, 2006), citing the use of this imaging technology to 
provide precise measurements and to reduce examiner bias as the participant is generally 
not seen in person by the researcher conducting the measurements of the features.  
 
Automated morphology assessment is a relatively new method to aid in the identification of 
morphological variants and genetic disorders. One of the early studies on the use of an 
automated morphology analysis systems was published by Aldridge et al. (2011) and 
involved a digital system (i.e., 3dMD Cranial System) to acquire three-dimensional (3D) 
facial images and measurements of the faces from boys diagnosed with ASD and TD 
controls. The study found differences in the facial features of the boys diagnosed with ASD 
compared with controls and was able to identify subgroups of boys with ASD based on 
facial dysmorphology who had distinct clinical and behavioral findings. The study 
concluded that the use facial dysmorphology as a biomarker for early identification and 
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subgrouping of ASD was promising. A later study by Obafemi-Ajayi et al. (2015) used 
similar methods to Aldridge et al. and found facial features could be used to separate boys 
with ASD into meaningful subgroups with differing clinical and behavioral profiles.  
 
More recent articles have been published on the use of the Facial Dysmorphology Novel 
Analysis system (FDNA; Boston, MA.) or the technology behind it called DeepGestalt 
(Gurovich et al., 2017; Gurovich et al., 2019). DeepGestalt uses facial recognition software 
to analyze simple two-dimensional (2D) images to detect potential dysmorphic features and 
the relationship of these features to genetic syndromes (Gripp, Baker, Telegrafi, & 
Monaghan, 2016; Gurovich et al., 2017; Gurovich et al., 2019). To use the DeepGestalt 
system, a user submits a photo through the web platform of Face2Gene (F2G), which is 
freely available to medical professionals and researchers. The system first detects the face 
and then 130 facial points. From this, the system is able to measure areas on the face to help 
detect dysmorphic features along with comparing the facial image with a gestalt associated 
with syndromes the system is trained to detect (Basel-Vanagaite et al., 2016; Gurovich et 
al., 2017; Gurovich et al., 2019). When using F2G, users receive a list of potential genetic 
syndromes that are most closely related to the gestalt image produced through the use of the 
system and also a heat map of the participant’s facial image, demonstrating areas in red that 
are most similar to those of others with the listed potential genetic syndromes (Basel-
Vanagaite et al., 2016; Gurovich et al., 2017; Gurovich et al., 2019; Lumaka et al., 2017).  
 
Recent studies have demonstrated F2G to be as good as or superior to clinical assessments 
performed by trained health care providers in identifying individuals with a variety of 
genetic conditions (i.e., mutations in the BAF complex genes in Gripp et al., 2016; XLHED 
phenotype in Hadj-Rabia et al., 2016; Cornelia de Lange in Basel-Vanagaite, 2016; 
Emmanuel and Pallister-Killian Syndromes in Liehr et al., 2017; Fetal Alcohol Syndrome 
and Alcohol-Related Neurodevelopmental Disorder in Valentine et al., 2017; inborn errors 
of metabolism in Pantel et al., 2018; and Down syndrome in Vorravanpreecha, 
Lertboonnum, Rodjanadit, Sriplienchan, & Rojnueangnit, 2018). Gurovich et al. (2017) 
specifically report that F2G has a 91% accuracy rate in identifying the correct disorder 
within the top 10 syndromes it lists for individuals for over 215 genetic syndromes. 
Gurovich et al. also note the system has been trained on a publicly available dataset of 
nearly 500,000 images from nearly 11,000 individuals and then refined on a proprietary 
database of images of participants with over 2500 genetic syndromes from F2G. One of the 
primary advantages of F2G is that it does not require the expensive and sophisticated 
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equipment needed to take 3D images like what was used in the study by Aldridge et al. 
(2011). Instead, facial photographs taken with a standard camera or phone can be used 
(Basel-Vanagaite et al., 2016; Gurovich et al., 2017). Additionally, F2G has the potential to 
be used by medical professionals and researchers who have limited access to trained 
dysmorphologists or clinical geneticists to be able to screen patients or participants, 
respectively, for genetic syndromes (Hadj-Rabia et al., 2017).  
1.9 MORPHOLOGICAL VARIANTS IN NDDs 
1.9.1 Morphological Variants in ASD 
Evidence has demonstrated the presence of morphological variants in approximately 10-
20% of the individuals with ASD (Angkustsiri et al., 2011; Miles & Hillman, 2000; Miles 
et al., 2005; Wong et al., 2014). Many of these studies have attempted to explore if 
individuals with ASD have particular morphological variants. Some of these studies report 
morphological variants that are more common in individuals with ASD, while others report 
that the overall number of morphological variants, rather than specific variants, is elevated 
in individuals with ASD.  
1.9.1.1 Specific Morphological Variants in ASD 
Tripi et al. (2008) specifically found abnormal head circumference (i.e., macrocephaly), 
abnormal cephalic index (i.e., dolichocephalic), and abnormal palates (i.e., high steepled) 
were more common in children diagnosed with ASD compared with TD controls. In the 
publication describing validation of the Autism Dysmorphology Measure, Miles et al. 
(2008) reported that in 25 of the 34 body regions assessed in their study were statistically 
significantly different (p<.05) between dysmorphic and non-dysmorphic participants with 
ASD. These regions included fingers/thumbs, oral cavity, nails, nose structure, face, 
philtrum, eyelids/palpebral fissures, mouth and lips, hair growth pattern, cranial shape, 
eyebrows, nose size, genitalia, stature, ear structure, feet, hands, forehead, abdomen, eye 
placement, back and spine, upper limbs, thorax and shoulders, teeth, and neck. Wong et al. 
(2014) conducted a study on over 1200 children with ASD exploring a variety of 
morphological variants and found macrocephaly, prominent forehead, big ears, and 
hypertelorism as the most commonly occurring morphological variants.  
 
Studies have also examined the association between birth defects and/or congenital 
anomalies with a diagnosis of ASD and have found that children with ASD are more likely 
to have congenital anomalies (Schendel, Autry, Wines, & Moore, 2009; Timonen-Soivio et 
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al., 2015; Wier, Yoshida, Odouli, Grether, & Croen, 2006). One of the studies explored the 
presence of congenital anomalies, including some MPAs, specifically in a Nordic 
population (i.e., Finnish) of children with ASD (Timonen-Soivio et al., 2015). The study 
looked at the association between anomalies that were identifiable through a national 
database and the presence of a diagnosis of ASD and found several anomalies that were 
more likely to be present in individuals with ASD compared with matched controls. These 
anomalies included hypertelorism, hydrocephalus, dysmorphic facial features, high palate, 
macrocephaly, coloboma, and cataracts. In the same study, children with concurrent ID and 
ASD were even more likely to have anomalies than those with ASD alone in several body 
systems (i.e., eye, face/neck, cardiovascular, central nervous system, gastrointestinal, 
genitourinary, and musculoskeletal).  
 
Some studies have also focused only on the facial region in the assessment of 
morphological variants due to the connection between the brain and face developing 
simultaneously in utero (Aldridge et al., 2011; Hammond et al., 2008; Obafemi-Ajayi et al., 
2015). A recent commentary reviewed the facial findings in studies to date in participants 
with ASD and described some similar facial morphological variants, notably facial 
asymmetry, along with reported facial masculinity in both boys and girls with ASD 
compared with TD controls (Boutrus et al., 2017). Similarly, other recent studies have 
identified hypermasculinized facial features in both boys and girls with ASD compared 
with controls and less feminine facial features in females with ASD (Bejerot et al., 2018; 
Tan et al., 2017). 
1.9.1.2 Overall Number of Morphological Variants in ASD 
Although various studies have explored the presence of specific morphological variants in 
children with ASD, they have failed to produce a consistent list of variants identified across 
studies. Therefore, it may be more useful to examine the number of morphological variants 
as a way to determine if some type of embryological or fetal insult or genetic aberration 
may have occurred during development that contributed to not only the variant, but 
potentially also to a diagnosis of ASD. In fact, Ozgen and colleagues (2010) conducted a 
meta-analysis comparing effect sizes among seven studies exploring the number of MPAs 
specifically and found significantly higher numbers of MPAs for participants with ASD 
compared with TD controls, supporting the clinical assessment for the number of MPAs in 
particular as a potential biomarker for ASD. Later, Ozgen et al. (2013) utilized a checklist 
of 683 major and minor anomalies and found individuals with ASD had on average, 10.6 
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MPAs (range 4-22), which was significantly different compared with individuals in the 
control group who had only 5.7 MPAs (range 2-13). Subsequently, the number of MPAs, 
rather than specific MPAs, may be helpful in distinguishing individuals with ASD from 
other NDDs or TD.  
 
One study to date has examined dysmorphology in twins in relation to a diagnosis of ASD, 
but the assessment was based only on a small number of items that were part of the 
previously mentioned Waldrop scale and the analyses and subsequent results were only 
minimally described (Bailey et al., 1995). The study did show that the proband most often 
had a higher number of MPAs compared with their co-twin, in twin pairs who were 
discordant for a diagnosis of ASD. 
 
A handful of studies have used the presence of morphological variants to categorize 
children with ASD into subgroups with distinct clinical and/or behavioral phenotypes, 
including severity of ASD (Aldridge et al., 2011; Miles & Hillman, 2000; Miles et al., 
2005; Obafemi-Ajayi et al., 2015; Wong et al., 2014). An additional study correlated the 
presence of dysmorphology with treatment outcomes in children receiving early intensive 
behavioral intervention (EIBI) in ASD (Stoelb et al., 2004). The study found that children 
lacking dysmorphic features were most likely to have better scores on a performance scale 
measuring attainment of EIBI treatment milestones at both six and 12 months post-
treatment. The ability to use the clinical assessment for morphological variants as a possible 
way to help classify individuals with NDDs into subgroups could have implications for 
future diagnosis, treatment, or prediction of outcomes. 
1.9.1.3 Finger Digit Ratio in ASD 
The ratio comparing the length of the 2nd finger digit to the 4th finger digit, often referred 
to as the 2D:4D ratio, is another type of physical feature that has been explored quite 
extensively in the field of ASD. Typically, in males, the second digit is shorter than the 
fourth digit. In comparison, females generally have a more equal length of the second and 
fourth digits (Zheng & Cohn, 2011). The differences in these digit lengths is believed to be 
due to fetal hormone exposure, with higher levels of testosterone resulting in greater 
differences in length between the second and fourth digits (Galis, Ten Broek, Van Dongen, 
& Wijnaendts, 2010; Hampson, Ellis, & Tenk, 2008; Lutchmaya, Baron-Cohen, Raggatt, 
Knickmeyer, & Manning, 2004; Malas, Dogan, Evcil, & Desdicioglu, 2006; Manning, 
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Bundred, & Flanagan, 2002; Manning, Scutt, Wilson, & Lewis-Jones, 1998; Manning, 
Stewart, Bundred, & Trivers, 2004; Voracek & Dressler, 2007). 
 
Research on the digit ratio in NDDs has primarily been done with ASD, in part, due to the 
extreme male brain theory (Baron-Cohen, Knickmeyer, & Belmonte, 2005), which suggests 
the influence of testosterone on the development of ASD. Evidence on the association 
between ASD and the ratio is inconsistent. Some studies have found lower 2D:4D ratios 
associated with ASD (Al-Zaid, Alhader, & Al-Ayadhi, 2015; de Bruin, de Nijs, Verheij, 
Verhagen, & Ferdinand, 2009; Honekopp, 2012b; Manning, Baron-Cohen, Wheelwright, & 
Sanders, 2001). Conversely, a recent, large study found no relationship between ASD 
diagnosis and the ratio (Guyatt, Heron, Knight Ble, Golding, & Rai, 2015). In one of the 
rare studies on the digit ratio in individuals with a variety of NDDs, as well as psychiatric 
disorders, de Bruin et al. (2009) identified lower 2D:4D ratios in males with ASD or 
ADHD compared with those with anxiety disorders or TD. The ratio has been studied once 
previously in twins, but only those with TD (Voracek & Dressler, 2007). The main finding 
of the study was that the ratio was highly heritable (with estimates around 80% for genetic 
effects). 
1.9.2 Morphological Variants in ADHD 
Older studies have primarily examined the relationship between hyperactivity and/or 
attention deficit disorder with MPAs in children and have demonstrated mixed results. 
Pomeroy, Sprafkin, and Gadow (1988) and Accardo et al. (1991) found no association 
between MPAs and the presence of hyperactivity or attention deficit disorder, while 
Waldrop et al. (1968), Quinn and Rapoport (1974), and Gualtieri et al. (1982) found 
significantly higher numbers of MPAs in children diagnosed with attention deficit disorder, 
hyperactivity, or ADHD. A study by Waldrop and Goering (1971) also found a relationship 
between an increased number of MPAs and presence of behavioral variables related to 
hyperactivity in an older sample of school age boys, but not for girls. A more recent study 
by Minahim and Rohde (2015) examined adults diagnosed with ADHD and found a 
significant association with the diagnosis and an increasing number of MPAs. Examples of 
MPAs found by Minahim and Rohde included hair whorls, high palate, clinodactyly, gap 
between first and second toes, and a thin upper lip. As evidence regarding the presence of 
morphological variants in individuals with ADHD is more limited, further studies are 
needed to explore both the type and number of morphological variants in individuals with 
ADHD and whether or not they may serve as a biomarker for ADHD. 
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1.9.3 Morphological Variants in other NDDs 
Morphological variants have been only minimally studied in other NDDs beyond ASD and 
ADHD. An older study by Pomeroy et al. (1988) used a standardized checklist to determine 
developmental delay, including factors related to language and motor delays and learning 
difficulties. The study found a significant relationship between higher amounts of MPAs 
and the presence of developmental delay. In studies by Accardo et al. (1991) and Links et 
al. (1980), the researchers explored the relationship between MPAs and ID and found a 
significant association between scores on a dysmorphology measure (i.e., modified 
Waldrop scale) and intelligence quotient (IQ). However, Accardo et al. found that as IQ 
increased, the score on the dysmorphology measure also increased, whereas Links et al. 
found that children with ASD with higher numbers of MPAs were more likely to have 
lower IQs. A more recent study by Ulovec and colleagues (2004) found significant 
differences in the number of MPAs in children with developmental delays (including ID 
and visual and auditory delays) compared with children without delays. Children with 
delays had significantly higher numbers of MPAs (average of 3.61 MPAs in children with 
developmental delays compared with 1.70 MPAs in TD children). Angkustsiri et al. (2011) 
explored MPAs in children with developmental delay (defined as low cognitive and 
adaptive function) compared with those with ASD and TD and found significantly higher 
ratings of dysmorphology (3 or more MPAs) in children with developmental delay (nearly 
50%), compared with ASD (17.4%) and TD (5.4%). As previously mentioned, de Bruin et 
al. (2009) examined 2D:4D finger digit ratios in individuals with a variety of NDDs and 
psychiatric disorders and found lower ratios in individuals with both ASD and ADHD 
compared with individuals with anxiety or TD controls.  
1.9.4 Morphological Variants and Genetics 
Morphological variants have been explored by researchers in the area of NDDs primarily 
because they may suggest underlying genetic and/or environmental perturbations that 
affected early embryogenesis, resulting in both the variant and neurodevelopmental 
disorders like NDDs (Accardo et al., 1991; Angkustsiri et al., 2011; Dawson et al., 2009; 
Gualtieri et al., 1982; Jones, 2013; Manouilenko et al., 2014; Miller et al., 2005; Minahim 
& Rohde, 2015; Ozgen et al., 2010; Ploeger et al., 2010). Genetic testing is recommended 
for all children undergoing diagnosis of ASD and further testing may be recommended in 
the event that the clinical assessment, review of family history, and/or co-morbid conditions 
indicate a possible underlying genetic condition (Schaefer et al., 2013). Genetic testing is 
also recommended in children with developmental disabilities and children with multiple 
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congenital anomalies (Miller et al., 2010). As a result, the assessment for morphological 
variants is one way health care providers may determine children and adolescents who 
would benefit from further genetic testing. Despite recommendations for such assessments 
as part of the diagnosis of NDDs such as ASD and ADHD (Johnson et al., 2007, NICE, 
2018, Robert  et al., 2017), little is known how often these occur and/or the training and 
level of expertise of health care providers needed to be able to perform these often 
subjective and complicated assessments. 
 
Several studies have demonstrated a relationship between morphological variants, including 
MPAs and congenital anomalies, and the presence of genetic aberrations like CNVs (Engels 
et al., 2007; Girirajan et al., 2011; Miles & Hillman, 2000; Miles et al., 2005; Tammimies 
et al., 2015). Miles and colleagues (2000; 2005) demonstrated higher percentages of 
individuals with dysmorphology who had detectable genetic syndromes. Engels et al. 
(2007) found abnormal facial features in the study participants with ID who also had CNVs 
and concluded that the severity of the phenotype of the participants was based on the 
number of genes in the region of the CNV rather than the size. In the study by Girirajan et 
al. (2011), individuals with ID and multiple congenital anomalies had increased CNV 
burdens compared to those with just ID alone. Tammimies et al. (2015) found that children 
with increasing morphological variants were more likely to have higher diagnostic yields 
through genetic testing, especially using combinations of genetic testing methods like CMA 
and whole exome sequencing (WES). These studies together support the importance of the 
physical examination for morphological variants in the diagnosis of NDDs like ASD in 
help determine children who would most benefit from next steps like genetic testing to 
uncover the potential etiology of the disorders. 
1.9.5 Morphological Variants and Neuroimaging 
It has been said that the “face predicts the brain” (Demyer, Zeman, & Palmer, 1964), as the 
development of both the face and brain occur simultaneously in utero and the neural crest 
cells developing the facial region are derived from the dorsal neural tube, which eventually 
is associated with sensory functions in the nervous system (Marcucio et al., 2015). Because 
of these connections, along with molecular signals guiding the growth and development of 
these two body systems, the development of the face is highly dependent on the 
development of the brain (Marcucio et al., 2015) and morphological variants in the facial 
region may mirror abnormal brain development (Cheung et al., 2011; Demyer et al., 1964).  
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Although MRI scans are not routinely recommended in the assessment of children with 
NDDs such as ASD (Filipek et al., 2000), some studies have specifically explored structural 
brain abnormalities in individuals with morphological variants such as MPAs (Miles & 
Hillman, 2000; Miles et al., 2005; Wong et al., 2014) due to the connection between the 
development of the brain and the face (Cheung et al., 2011; Jones, 2013). Miles and 
Hillman (2000), Miles et al. (2005), and Wong et al. (2014) all found children with ASD 
and increased dysmorphic features were significantly more likely to have abnormal MRI 
scans. For example, Miles and Hillman (2000) identified structural alterations affecting the 
frontal, temporal, parietal, and cerebellar lobes, along with the corpus callosum in 
individuals with MPAs using MRIs. These studies suggested the possibility of using 
information related to both morphological variants and abnormal brain MRIs to classify 
individuals into subgroups in order to help determine etiology and prognosis for individuals 
with ASD, along with the future potential for tailored treatment options that may vary based 
on subgroup classification.  
1.9.6 Limitations of Previous Research on Morphological Variants in NDDs 
There are multiple limitations in studies to date on morphological variants in NDDs, 
including limitations in samples, measures and assessments, and methods.  
1.9.6.1 Samples 
Very little evidence has shown to what degree a relationship exists between morphological 
variants and the presence of NDDs broadly, especially with studies using well-controlled 
genetic backgrounds. Studies exploring morphological variants in individuals with NDDs 
as an overarching diagnostic entity, versus just ASD or ADHD alone, could be valuable, 
especially considering the substantial overlap among NDD diagnoses. In fact, Ozgen et al. 
(2013) discussed the need to examine variants in individuals with other NDDs beyond 
ASD, including ADHD, as well as other psychiatric disorders in their study exploring the 
predictive power of morphological variants in distinguishing individuals with ASD from 
those with TD. Additionally, studies exploring the presence of morphological variants in 
twins have only been minimally explored in the literature to date (Bailey et al., 1995; 
Voracek & Dressler, 2007). Since the twin design is a powerful tool in research to explore 
the genetic and environmental contributions to phenomena of interest, previous researchers 
such as Links et al. (1980) and Compton et al. (2011) have called for more studies in twins 
in order to better understand the heritability of morphological variants such as MPAs. Links 
et al. specifically recommended studies of MZ twins discordant for MPAs to explore 
potential environmental contributions to the development of morphological variants.   
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1.9.6.2 Measures/Assessment 
Despite the popularity of the Waldrop scale for measuring MPAs, it presents major 
limitations including the small number of items assessed, low sensitivity, and low interrater 
reliability (Cheung et al., 2011). Furthermore, the scale was developed based on MPAs in a 
specific genetic disorder (i.e., Down syndrome). A study by Sivkov and Akabaliev (2003) 
examined the use of the scale in TD subjects and found poor internal consistency in the 
scale and recommended the creation or use of more reliable scales in the study of 
morphological variants. As noted earlier, the aforementioned Autism Dysmorphology 
Measure (Miles et al., 2008) has been used in only a few other studies to date and has only 
been validated to assess dysmorphology in children with ASD rather than other types of 
NDDs like ADHD, which may overlap with ASD.  
 
The assessment of morphological variants overall is highly subjective. Even exams 
performed by highly trained and experienced individuals are subject to examiner bias. 
Automated facial analysis systems (e.g., F2G, 3dMD, etc.) now exist to measure some 
morphological variants objectively, thereby limiting examiner bias. Research is currently 
underway or has already been conducted (Aldridge et al., 2011; Gurovich et al., 2017; 
Obafemi-Ajayi et al., 2015; Pantel et al., 2018; Tripi et al., 2019) to explore the ability of 
these technologies to conduct morphological assessments, though further studies using this 
technology to assess morphological variants, especially in comparison to in-person clinical 
assessments, are needed.   
1.9.6.3 Methods 
Ozgen and colleagues (2011) specifically addressed limitations in studies to date on MPAs 
in children with ASD in particular and noted the following issues: “a. lack of 
standardization of the nomenclature and the absence of uniform diagnostic criteria; b. 
patients with different ethnic backgrounds were included; c. patients were not physically 
examined by the investigators specifically for the study; d. lack of control data or use of 
biased populations; e. relatively small sample sizes; f. no reports on interrater reliability; g. 
lack of consideration of gender effect” (p. 24). Even though these issues were identified 
almost a decade ago, research in the area of morphological variants only appears to be 
starting to address some of these limitations. For example, the introduction of HPO 
terminology in the past decade has helped standardize the language used to describe 
morphological variants. Additionally, the use of automated systems may help decrease 
some of the challenges and bias that may exist when humans examine patients with 
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different ethnic or racial backgrounds, as was found to be the case in a recent study with 
F2G (Lumaka et al., 2017).  
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2 AIMS 
The aims of this doctoral thesis are to examine morphological variants associated with 
NDDs using a unique cohort of twins with detailed clinical and automated morphological 
assessments, neuroimaging, and molecular genetics (1) to identify characteristics of 
morphological variants that can support NDD screening and risk assessment, (2) to test 
whether it is possible to obtain reliable morphological assessments using low-cost 
automated technology, and (3) to utilize the twin design to explore the potential genetic and 
environmental influences on the development of morphological variants. The hypotheses 
for the various studies are that (1) an excess of clinically and automatically assessed 
morphological variants will be present individuals with NDDs compared with TD controls, 
(2) there will be a high convergence of clinical and automated morphological assessment, 
and (3) the presence of morphological variants will be highly correlated in MZ compared 
with DZ twins. 
2.1 STUDY I– MINOR PHYSICAL ANOMALIES IN NEURODEVELOPMENTAL 
DISORDERS: A TWIN STUDY 
The aims of Study I were 1) to explore the type and number of MPAs in twin pairs from 
RATSS who were concordant or discordant for NDD phenotypes and TD twin controls and 
2) to examine the relationship between morphological variants in twins pairs by zygosity.  
2.2 STUDY II– 2D:4D RATIO IN NEURODEVELOPMENTAL DISORDERS: A 
TWIN STUDY  
The aim of Study II was to explore differences in the 2D:4D ratio in twin pairs from 
RATSS who were concordant or discordant for NDD phenotypes and TD twin controls. 
2.3 STUDY III– NEURODEVELOPMENTAL AND MORPHOLOGICAL 
PHENOTYPES OF CARRIERS WITH 12q12 DUPLICATIONS 
The aim of Study III was to describe the neurodevelopmental, behavioral, and 
morphological phenotype of a twin pair from RATSS who were found to have an inherited 
duplication on chromosome 12, along with phenotypes from participants found through an 
international database and the literature who had a similar duplication.  
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2.4 STUDY IV– CLINICAL VERSUS AUTOMATED ASSESSMENTS OF 
MORPHOLOGICAL VARIANTS IN TWINS WITH AND WITHOUT 
NEURODEVELOPMENTAL DISORDERS  
The aims of study IV were to 1) determine agreement between clinical assessment of 
morphological variants (which were assessed in Study 1) and automated assessment of 
morphological variants (i.e., using F2G); 2) report on the use of automated assessment of 
facial images of twin pairs recruited through RATSS to examine the type and number of 
morphological variants present in participants in relationship to the presence or absence of 
NDD diagnoses; and 3) determine if faces of those with NDDs are distinguishable from 
those with TD.  
2.5 SIGNIFICANCE OF STUDIES 
The significance of these studies relates to both clinical work and to society as a whole. The 
use of assessments for morphological variants, including automated assessments, to identify 
children who may be at risk for NDDs, has the potential to be a valuable and cost-effective 
tool for clinical providers to help support diagnosis of NDDs. These assessments may also 
allow subgrouping of individuals with various NDDs based on the presence of 
morphological variants, which could be valuable for future treatment or interventions. 
Although previous studies have looked at the use of provider-completed measures to 
determine the presence of morphological variants, assessments using automated 
technologies (such as F2G) could help improve accuracy and may reduce the time and costs 






3.1 ETHICAL CONSIDERATIONS 
3.1.1 Permits and Consent 
Prior to the start of the RATSS project, ethical approval was received from the national 
Swedish and regional ethics board in Stockholm (dnr: 2016/1452-31 and dnr: Ö32-210). 
Before participation in the RATSS, participants and their parents/legal guardians (if 
applicable) provided consent for their involvement in the study. Since children were 
involved in the study, the assent of the children and the consent of the parents or legal 
guardians were obtained prior to participation. As some participants had cognitive 
impairments, it was essential to determine through interviews, medical records, clinical 
judgment, and discussion with legal guardians (when applicable) whether or not these 
participants were able to provide informed consent. This was done to ensure participants 
were aware of their involvement in the study and their rights as a research study participant 
(e.g., ability to decline study procedures, withdraw participation in the study, right to obtain 
information stored on them, etc.). The consent form for the study was approved by the 
ethical review board and was sent to the participants and their parents or legal guardians in 
advance, as well as reviewed again at the start of the in-person visit for the study. 
Participants and parents or legal guardians were offered a chance to ask questions and could 
select which parts of the study they provided assent/consent for participation. No 
participants were required to complete any part of the study for which they did not want to 
be involved.  
3.2 RISKS AND BENEFITS 
Researchers designed the RATSS study to maximize benefits and minimize risk to 
participants and their families. A research nurse accompanied the participants and their 
parents or legal guardians through most of the data collection procedures and was available 
for questions before, during, and after the in-person visit to the research center. Participants 
were offered compensation for the burden of participation in the study in a form of a gift 
card commensurate with the time and effort required of the participants and their parents or 
legal guardians to take part in the study. Participants were also provided reimbursement for 
transportation to the study site, loss of income or any other related expenses, and were 
offered accommodation at a nearby hotel if this was needed to participate in the study. The 
study procedures were performed in such a way to minimize fatigue on the participants and 
their families. With the various biological samples collected on participants in the RATSS 
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project (i.e., saliva, blood, MRI scans, etc.), participants were informed of any 
abnormalities identified from the samples (e.g., pathological or clinically significant 
variants) and were referred for any previously undetected problems. Prior to participation in 
some elements of the study (e.g., neuroimaging), safety questionnaires were completed by 
the participants to determine eligibility for participating in the particular element of the 
study. Feedback on the results of behavioral testing was also provided to the participants, if 
requested.  
 
Since personnel in the RATSS collected data and biological samples from participants, 
confidentiality was critical and was maintained throughout the study by all research staff 
involved in RATSS. Personal data was handled in accordance with Swedish law. Each 
participant was assigned a unique identification code for the project. Biological samples 
were handled and stored according to Swedish law. The studies in this thesis specifically 
examined physical features in participants, both through in-person physical examinations 
and through medical photography. The use of photography in particular to identify 
individuals at risk for neurodevelopmental disorders was recently discussed in an article on 
the ethics of facial phenotyping by Kong (2019). Kong specifically discusses issues that 
arise when researchers use photographs to identify features in participants with NDDs that 
may further stigmatize individuals or even lead to issues resulting in eugenics. These 
concerns brought forth by Kong (2019) are extremely important to consider in studies such 
as the ones included in the thesis, which all examine physical or facial features in 
participants. To address these issues, all participants in RATSS were informed of the 
purpose for conducting physical examinations, as well as medical photographs of their 
bodies, along with their rights as research participants to participate in components of the 
RATSS that included physical examinations, as well as medical photography.   
 
RATSS recruits a sample of twin pairs, particularly MZ twins discordant for ASD and 
ADHD, along with DZ twins and TD control twins, in order to collect a variety of 
behavioral data and biological samples from the twins with the overall aim to “understand 
the complexity of genotype-environment-phenotype interactions in ASD and ADHD” 
(Bölte et al., 2014, p. 164). In accordance with that aim, RATSS intends to benefit 
participants with NDDs broadly through “the identification of environmentally mediated 
biomarkers, the emergence of candidates for drug development, translational modeling, and 
new leads for prevention of incapacitating outcomes” (Bölte et al., 2014, p. 165). 
Participants were recruited from the entirety of Sweden and targeted recruitment was done 
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to ensure the sample had an adequate number of participants with suspected or diagnosed 
NDDs and did not disproportionately exclude any groups that were necessary to achieve the 
overall study aim.  
3.3 STUDY DESIGN AND PARTICIPANTS 
3.3.1 Roots of Autism and ADHD Twin Study in Sweden 
The studies in this thesis were based on the matched case-control or the co-twin control 
design within the RATSS (Bölte et al., 2014).  
3.3.1.1 Subsamples  
Participants in the studies in this thesis from RATSS were recruited from 2011 to 2017 
through a variety of methods. The primary source of recruitment for the twin pairs is 
through the Child and Adolescent Twin Study in Sweden (i.e., CATSS, Anckarsäter et al., 
2011). Additional methods of recruitment include advertisements in journals for national 
interest organizations, referrals from clinical units (e.g., child psychiatry, habilitation 
centers, pediatric clinics), and the Swedish patient registry (Bölte et al., 2014). Initial 
recruitment of participants in the project focused on children as young as eight years of age 
and adolescents, but has expanded in recent years to include young adults. As of June 2019, 
207 twin pairs and 2 trios of triplets (representing 220 MZ individuals, 186 DZ individuals, 
and 14 individuals with pending zygosity) have participated in the RATSS. Table 1 outlines 
the subsamples from RATSS for each of the studies in this doctoral thesis, including the 
number of participants in each study, the number of MZ versus DZ twins, percentage of 
males to females, percentage of twins with diagnoses of NDDs versus those with TD, and 
the mean, standard deviation, and range of ages of participants. Study III involves a rare, 
inherited genetic duplication discovered in a twin pair from RATSS and an additional five 
participants that were not part of RATSS that are included in the case series that were 
identified from DECIPHER, a genetic variant database, and through a previously published 
study (Wang et al., 2010). The information related to these five participants is not included 
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Table 1. Subsamples from RATSS by study. 
Study # of 
Participants 
# of MZ 
Twin Pairs 
# of DZ 
Twin Pairs 









 (M, SD) 
I 116 51 7 57:43 24 32 53 47 9-23 years 
(14.0, 3.4) 
II 238 70 49 55:45 19 27 44.5 55.5 8-29 years 
(16.2, 5.2) 
III 2 1 N/A 2 Males 100 100 100 0 17 years 
(NA) 
IV 290* 81 59 56:44 25 28 46.5 53.5 8-31 years 
(16.2, 5.3) 
#=Number; %= Percentage; MZ= Monozygotic; DZ= Dizygotic; M:F=Male:Female Ratio; 
ASD=Autism Spectrum Disorder; ADHD=Attention-Deficit/Hyperactivity Disorder; 
NDD=Neurodevelopmental Disorder; TD=Typical Development; M=Mean; SD=Standard Deviation 
*Includes 1 pair with pending zygosity 
3.3.1.2 Procedures/Data Collection 
Data collection in the RATSS took place generally over the course of three days in 
Stockholm, Sweden. The participants were assessed and samples were collected by trained 
and licensed behavioral and medical professionals. Behavioral data and biological samples 
collected in RATSS are illustrated in Figure 3, with those of particular importance to this 
doctoral project highlighted in bold and described in further detail below, including 
morphological assessments, behavioral assessments, neuroimaging, and saliva.  
 
Figure 3. Illustration of biological and behavioral samples collected from twin pairs in 
RATSS. 
3.3.1.2.1 Morphological assessments 
Morphological assessments in the RATSS included three general elements: 1) in-person 
clinical assessments; 2) medical photography of participants’ hands and measurement of 
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finger digits; and 3) medical photography of the participants’ faces that were then scanned 
for facial morphological variants (FMVs) using F2G.   
 
For participants recruited in RATSS between 2011 and 2013, two experienced, clinical 
geneticists conducted complete or nearly complete in-person clinical assessments of 116 
participants. The clinical geneticists together developed a comprehensive head-to-toe 
checklist of 217 morphological variants, with an additional 8 variants for a genital exam in 
males only. The checklist was originally developed in Swedish and based on the London 
Dysmorphology Database, Elements of Morphology, and long-standing clinical expertise. 
The checklist was later translated into English by this PhD candidate, who is a pediatric 
nurse fluent in English, with the assistance of a pediatric psychiatrist, research nurse, and 
geneticist who were all fluent in Swedish and English. The translated checklist in English 
was then reviewed by the two geneticists who originally developed it to ensure the proper 
Swedish-to-English translation of the terms used to describe the morphological variants. 
The checklist was then further translated into HPO terms, and the two geneticists again 
reviewed and approved the translation into HPO terms where appropriate (see Appendix 1 
for original and translated checklist). The checklist was used to guide and document the in-
person clinical assessments, which took about 1 hour to complete for each twin pair. The 
assessments were primarily jointly completed by both geneticists and any disagreements 
between the geneticists on findings were resolved on the spot. The geneticists marked either 
“yes” or “no” on the checklist regarding the presence of each variant in the individual 
participants. In general, the presence a morphological variant resulted in a score of “1” for 
each variant identified on the participant to create a total score of the number of 
morphological variants present in each individual.  
 
Medical photos (2D) were taken of both the right and left palmar and dorsal surfaces of 
hands of participants in RATSS at the Karolinska Hospital Medical Photography Lab. 
Using the palmar surface photographs of participants’ hands, the 2nd and 4th finger digit (see 
Figure 4) were measured on both the right and left hands of participants by two raters. The 
measurements were taken from the midpoint of the arc defining the tip of both the 2nd and 
4th finger digit vertically to the most proximal crease of each finger digit in the palm of the 
hand with a program called ImageJ (Schindelin, Rueden, Hiner, & Eliceiri, 2015). The 
average of these measurements between Raters 1 and 2 was used to calculate the 2D:4D 
ratio. The raters were blinded to the participants’ diagnoses of NDDs versus TD. Both 
raters assessed the usability of the hand photographs to determine if there were 
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measurements for the 2nd or 4th finger digit on either hand that were unusable (e.g., digit not 
flat on table surface for photograph, hands or digits curled or cupped). If a participant 
lacked measurements by either rater for the 2nd or 4th finger digit on either the right or left 
hand due to the issues noted above, the participant (and their co-twin) were removed from 
the final analysis due to the inability to calculate an accurate 2D:4D ratio (i.e., 19 total twin 
pairs were removed).  
 
Figure 4. 2nd and 4th finger digit measurements. 
 
Facial photos (2D) were also taken of participants in RATSS in the Karolinska Hospital 
Medical Photography Lab. The facial photos were securely transferred to F2G and then 
analyzed anonymously through the DeepGestalt system for the presence of any FMVs 
based on HPO terminology. The DeepGestalt system first detects the face in each 
photograph and then 130 facial points which are used to take the measurements. The 
measurements are then fed into a deep convolutional neural network which results in a list 
2D 4D 
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of syndrome and gene matches (Basel-Vanagaite et al., 2016; Gurovich et al., 2017; 
Lumaka et al., 2017). From there, the system is able to provide a list of phenotypic features 
using HPO terms that are present in the individual based on the syndrome and gene 
matches. The features were reported back to the research team by F2G in a spreadsheet 
format. 
3.3.1.2.2 Behavioral assessments 
Participants in RATSS received a variety of assessments to help determine the presence of 
NDDs and other psychiatric conditions. The assessments primarily took place in-person 
during the study visit or were completed via questionnaires by the participants prior to or 
during the visit. The assessments were conducted by trained clinicians. Through a 
consensus process, the participants received diagnoses of NDDs or TD. Additionally, 
concordancy related to diagnoses for the twin pairs was determined during this process. For 
example, if one twin was diagnosed with ASD and their co-twin was diagnosed with 
ADHD, then the pair was considered ASD Discordant, ADHD Discordant, but NDD 
concordant. The various behavioral assessments conducted that are of interest to this 
doctoral thesis are included in Table 2, along with their reference and purpose overall in the 
RATSS.  
 
Table 2. Description of instruments from RATSS used in studies. 
Instrument Reference Purpose of Instrument in RATSS 
Adult Behavior Checklist 
(ASEBA) 
Achenbach, T.M., & Rescorla, 
L.A. (2003). Manual for the 
ASEBA Adult Forms & Profiles. 
Burlington, VT: University of 
Vermont Research Center for 
Children, Youth, & Families. 
General assessment of behavior 
and functioning in adults, includes 
scales on “Attention Problems” and 
“Total Problems” 
Autism Diagnostic Observation 
Schedule (ADOS-2) 
Lord, C., Rutter, M., DiLavore, P., 
Risi, S., Gotham, K., & Bishop, S. 
(2012). Autism Diagnostic 
Observation Schedule-2nd Edition 
(ADOS-2). Los Angeles, CA: 
Western Psychological Services. 
Diagnosis of ASD 
Autism Diagnostic Interview-
Revised (ADI-R) 
Rutter, M., Le Couteur, A., & Lord, 
C. (2003). The Autism Diagnostic 
Interview-Revised (ADI-R). Los 
Angeles, CA: Western 
Psychological Services. 
Diagnosis of ASD 
Child Behavior Checklist 
(ASEBA) 
Achenbach, T.M., & Rescorla, L.A. 
(2000). Manual for the ASEBA 
School-Age Forms & Profiles. 
Burlington, VT: University of 
Vermont Research Center for 
Children, Youth, & Families. 
General assessment of behavior 
and functioning in children, 
includes scales on “Attention 
Problems” and “Total Problems” 
Diagnostic Interview for ADHD 
in Adults (DIVA 2.0) 
Kooij, J.J.S. (2010). Diagnostic 
Interview for ADHD in Adults 2.0 
(DIVA 2.0). Amsterdam: Pearson  
Diagnosis of ADHD in adults 
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Instrument Reference Purpose of Instrument in RATSS 
Kiddie Schedule for Affective 
Disorders and Schizophrenia (K-
SADS) 
Kaufman, J., Birmaher, B., Brent, 
D., Rao, U., Flynn, C., Moreci, 
P.,…Ryan, N. (1997). Schedule for 
Affective Disorders and 
Schizophrenia for School-Age 
Children-Present and Lifetime 
Version (K-SADS-PL): Initial 
reliability and validity data. 
Journal of the American Academy 
of Child & Adolescent 
Psychiatry. 36(7), 980-988. 
doi:10.1097/00004583-199707000-
00021 
Diagnosis of ADHD in youth 
Leiter International Performance 
Scale- Revised 
Roid, G.H. & Miller, L.J. (1997). 
Leiter International Performance 
Scale-Revised: Examiner's Manual. 
Wood Dale, IL: Stoelting. 
Non-verbal intellectual abilities; 
diagnosis of ID  
Peabody Picture Vocabulary 
Test, Fourth Edition (PPVT-4) 
Dunn, L.M. & Dunn, D.M. (2007). 
Peabody Picture Vocabulary Test, 
4th Edition. San Antonio, TX: 
Pearson. 
Verbal intellectual abilities; 
diagnosis of ID  
Social Responsiveness Scale-2 
(SRS-2) 
Constantino, J.N. (2005). Social 
Responsiveness Scale (SRS). Los 
Angeles, CA: Western 
Psychological Services. 
Measurement of autistic traits 
Wechsler Adult Intelligence 
Scale-IV (WAIS-IV)  
Wechsler, D. (2003). WAIS-IV 
Wechsler Intelligence Scale for 
Adults 4th Edition: Technical and 
Interpretive Manual. San Antonio, 
TX: Pearson. 
IQ in adults; diagnosis of ID 
Wechsler Intelligence Scale for 
Children-IV (WISC-IV)  
Wechsler, D. (2003). WISC-IV 
Wechsler Intelligence Scale for 
Children 4th Edition Technical and 
Interpretive Manual. San Antonio, 
TX: Pearson. 
IQ in children; diagnosis of ID  
3.3.1.2.3 Neuroimaging 
Neuroimaging, in the form of MRI, was performed on participants in RATSS using a 3 
Tesla MR750 GE scanner at the Karolinska Institutet MR Center. Both T1 and T2 images, 
along with functional MRI (fMRI) and diffusion tensor imaging (DTI) were obtained 
through an approximately 50-minute scanning session on each participant who consented to 
the procedure and was eligible based on their medical history. The images obtained from 
the MRI were initially reviewed by clinical radiologists at the Karolinska Hospital for the 
presence of neuroradiological variants, including either incidental findings (IF) or 
pathological findings that required further clinical follow-up. Due to the number of 
radiologists reading the images over the 8-year span of the RATSS so far (2011-2019), an 
experienced, independent, pediatric neuroradiologist was recruited to re-read the T1 and T2 
images in a blinded fashion to conduct a standardized and consistent assessment of all 
participants’ MRI images for the presence of neuroradiological variants.  
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3.3.1.2.4 Saliva 
Saliva is obtained from both participants and their biological parents (if available) during 
RATSS to use for both zygosity and genetic testing. Details related to the extraction of 
DNA from these samples can be found in Stamouli et al. (2018). Genotyping was 
performed on the DNA using the Infinium PsychArray-24 v1.1 (Illumina Inc., San Diego, 
California, USA). The PLINK/1.07 software (Purcell et al., 2007) was used to confirm 
zygosity from genotype data by estimating the identify of descent after quality control was 
performed on the data and any single nucleotide variants with a minor allele frequency less 
than 0.05 were removed (Stamouli et al., 2018). For a few twin pairs, zygosity was 
determined either through a short tandem repeat kit (Promega Powerplex 21) or through a 
zygosity questionnaire used in CATSS (Willfors, Carlsson, et al., 2017). 
3.3.1.3 Statistical Methods 
Statistics utilized in this doctoral project included descriptive statistics, interrater 
agreement, receiver operating characteristic (ROC) curves, correlational statistics, tests of 
difference, and generalized estimating equations (GEE). Table 3 provides an overview of 
the methods used by study. SPSS version 24, R version 3.3.2, and R Studio version 1.0.44 
were used to perform the statistics. Further detail related to statistical methods can be found 
in the individual papers in this thesis.  
 
Table 3. Overview of statistical methods by study. 
Statistical Method Study I Study II Study III Study IV 
Descriptive statistics X X X X 
Interrater agreement X X  X 
ROC curves    X 
Correlational statistics X (Spearman) X (Spearman)   
GEE  X X  X 
Tests of difference X (Mann-Whitney U)   X (GEE) 
 
3.3.1.3.1 Descriptive statistics 
Descriptive statistics in this thesis were performed to describe the number, percentage, 
measures of central tendency [i.e., mean (M) and median (Md)], standard deviation (SD), 
and ranges of values. 
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3.3.1.3.2 Interrater agreement 
Measures of interrater agreement were used to compare assessments between clinical 
geneticists conducting in-person exams on participants and a physician trained in 
dysmorphology (Study I) or with the F2G findings (Study IV). Statistics related to 
agreement were calculated using the irr package (version 0.84) in R Studio.  
3.3.1.3.3 ROC curves 
ROC curves were calculated through the F2G Research Platform to examine if participants 
with NDDs could be differentiated from those with TD using facial features detected with 
the F2G system. ROC curves are useful in that they look at the amount of separation 
between two entities (Hajian-Tilaki, 2013). In the case of facial analysis of participants with 
NDDs compared with TD, the curve plots the true-positive rate (sensitivity) of being able to 
discriminate participants on facial features on the y-axis against the false-positive rate to 
create an area under the curve (AUC) (Hajian-Tilaki, 2013). AUC values nearing 1.0 
indicate increasing accuracy of the system in being able to discriminate among individuals 
with varying diagnoses, while values closer to 0.5 indicate a more random ability of the 
system to discriminate among individuals (Tape, n.d.).  
3.3.1.3.4 Correlational statistics 
Spearman correlations were used to assess the relationship between zygosity and 1) number 
of MPAs in twin pairs (Study I) and 2) 2D:4D finger digit ratios (Study II) due to the non-
normal distribution of the number of MPAs and finger digit ratios, respectively, in 
participants in the studies.  
3.3.1.3.5 GEE 
Since the RATSS involves data based on twins, standard correlational measures are not 
entirely appropriate due to the paired nature of the data and the fact that twins share some 
factors like environment and genetics and are, therefore, not independent (Carlin, Gurrin, 
Sterne, Morley, & Dwyer, 2005). The statistic used to calculate associations, as well as 
differences between variables, was twin modelling with GEE. The model examines 
associations and differences between-pairs and within-pairs. The between-pairs model 
operates like a standard linear or logistic regression, except that it accounts for the shared 
factors within twin pairs using clustered standard errors, while the within-pairs model 
specifically accounts for factors shared such as environment and genetics. In the within-
pairs model, Carlin et al. (2005) state that stronger beta values in MZ versus DZ twins 
indicate the potential role of the environment, while weaker beta values for MZ compared 
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with DZ pairs may indicate a stronger role of genetics as the MZ twin pairs are almost 
perfectly matched on genetic factors. Both beta values and odd ratios, including 
corresponding standard errors, 95% confidence intervals, and p-values, can be calculated 
using the GEE model. The drgee package (version 1.1.6) in R Studio (Zetterqvist, 
Vansteelandt, Pawitan, & Sjolander, 2016) was used to perform the GEE statistics in this 
thesis. 
3.3.1.3.6 Tests of difference 
The Mann-Whitney U test was performed to assess the significance of the difference in 
number MPAs that were identical and different in MZ versus DZ twins (Study I). The GEE 
model was used to compare the difference in the percentage of specific FMVs in those with 
NDDs to those with TD (Study IV).  
3.3.1.4 Variables explored by study 
The variables explored in this thesis through statistical analysis that were obtained through 
the biological and behavioral samples in the RATSS are listed in Table 4 below by study 
number. Further details related to these variables and how they were analyzed in each study 
can be found in the individual papers in this thesis.  
 
Table 4. Variables explored by study. 
Variables Study I Study II Study III Study IV 
NDD diagnosis X X X X 
Demographics X X X X 
IQ X X X X 
SRS X X  X 
ASEBA    X 
Count of physical anomalies 
(MPAs, FMVs, etc.)  
X   X 
2D:4D finger digit 
measurements/ratio 
 X   
MRI findings X    
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4 RESULTS  
4.1 STUDY I 
4.1.1 MPAs in ASD and other NDDs 
Descriptively, Study I found individuals with NDDs had higher median numbers of MPAs 
(Md=range of 4 to 9 MPAs by NDD diagnosis) compared with those with TD (Md=3 
MPAs). Statistically, however, higher MPAs were only significantly associated with a 
diagnosis of ASD (crude odds ratio =1.29, p=.047). Twin pairs concordant for ASD had the 
highest median number of MPAs (Md=9 MPAs). Due to the association of MPAs with 
ASD, autistic traits, as measured through the SRS-2, were also correlated with the number 
of MPAs and found to be significant in the entire sample [ß=3.02, Standard Error (SE)=.98, 
95% confidence interval=1.09 – 4.94, p=.002], indicating that every MPA present in an 
individual corresponded to an approximately 3-point increase in their SRS-2 score, 
indicating the presence of higher autistic traits.   
4.1.2 MPAs and IQ 
IQ was negatively associated with the presence of MPAs (ß=-.95, SE=.32, 95% confidence 
interval=-1.59 – -.32, p=.003), so that for every MPA present in an individual there was an 
approximately 1-point decrease in their IQ, indicating a trend for lower IQs in individuals 
with increasing MPAs.  
4.1.3 MPAs in MZ twins 
The number of MPAs were highly correlated in MZ (rs= .88, p<.001), but not DZ (rs= -.19, 
p<.676) twin pairs. MZ twin pairs had both the higher number of identical MPAs (Md=4) 
compared with DZ twins (Md=1; z=-2.764, p=.006) and a smaller median difference in 
specific MPAs present (Md difference=2) compared with DZ twins (Md difference= 4; z=-
1.066, p=.287).  
4.2 STUDY II 
4.2.1 2D:4D Ratio Relationships with Diagnoses of NDDs or ADHD 
Study II found only weak relationships between the diagnosis of NDDs and a lower 2D:4D 
finger digit ratio in both males (between-pairs model, ß=-.014, 95% confidence interval=-
.025 – -.002, p=.019) and females (within-pairs model, ß=-.017, 95% confidence interval=-
.035 – .000, p=.050), indicating a decrease in the ratio by either .014 for males or .017 for 
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females. Additionally, a weak relationship was found between a diagnosis of ADHD and a 
lower ratio in males (between-pairs model, ß=-.015, 95% confidence interval=-.027 – -.003, 
p=.012).  
4.2.2 2D:4D Ratio in Males Compared with Females 
Overall, males had a lower median 2D:4D finger digit ratio (Md for overall hand=.992, 
interquartile range=.970 and 1.015) in comparison with females (Md for overall 
hand=1.010, interquartile range=.981 and 1.031). When examining the ratio in the various 
NDDs by sex, males had lower Md ratios for each disorder compared with females.  
4.3 STUDY III 
4.3.1 Rare Genetic Duplication with Incomplete Penetrance in Twins and 
Others with MPAs and NDDs 
A genetic duplication affecting chromosome 12 long arm (12q12) was found in a twin pair 
in RATSS. Five other individuals with a similar size and location of duplication were 
identified through the literature or DECIPHER, a database including individuals with 
genetic abnormalities. Individuals with the duplication had learning difficulties, cognitive 
impairment, language and gross motor delays, and at least one NDD (i.e., intellectual 
disability, ADHD, ASD). Individuals with the duplication were primarily males with 
morphological variants present in head shape, forehead, eyes, vision, ears, nose, oral-facial 
region, and toe digits.  
4.4 STUDY IV 
4.4.1 Agreement between Clinical and Automated Assessment of 
Morphological Variants 
When comparing in-person clinical assessments of morphological variants to variants 
identified through F2G, agreement was high to complete (78.3 – 100%) for 36 FMVs 
mutually assessed by both raters, though this level of agreement was primarily based on the 
agreement between raters with the non-findings of FMVs. 
4.4.2 Facial Morphological Variants in Individuals with NDDs 
The number of FMVs was not associated with a diagnosis of a NDD in either the between-
pairs or within-pairs model. However, there was a weak association between IQ and the 
number of FMVs (ß=-1.538, 95% confidence interval=-2.961 – -.115, p=.0341), indicating 
that every one facial FMV present corresponded to a 1.5-point decrease in IQ. Facial 
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features of individuals with ASD, ADHD, and a diagnosis of any NDD were not 
significantly distinguishable from those with TD (AUC range .561-.584, p>.05).  
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5 DISCUSSION  
5.1.1 Discussion on Study Results 
The studies in this thesis found higher numbers of morphological variants, including MPAs 
and FMVs, along with lower 2D:4D finger digit ratios, in individuals with NDDs compared 
to those with TD. However, the statistical relationship between increasing morphological 
variants in individuals with diagnoses of NDDs was not always significant. Notable 
exceptions were the increasing numbers of MPAs in individuals with ASD and autistic 
traits found in Study I, similar to results from previous studies and a meta-analysis finding 
increased amounts of MPAs in individuals with ASD (Ozgen et al., 2013; Ozgen et al., 
2010). When looking at the relationship of morphological variants and IQ, studies I and IV 
found an association between increasing morphological variants and decreasing IQ, similar 
to an older study in participants with morphological variants and ASD by Links et al. 
(1980) where they also found lower IQs with the presence of morphological variants. 
 
Study I also points to the genetic basis for MPAs in particular, with MZ compared with DZ 
twins having both similar amounts, as well as types, of MPAs, even if the MZ twins did not 
share NDD diagnoses. The use of the twin design in the studies helped to determine the 
genetic nature of morphological variants, which has been called for previously in the 
literature by Links et al. (1980) and Compton et al. (2011), but was never before performed 
in a sample of participants with NDDs as an overarching diagnostic category.  
 
Lower finger digit ratios have been found previously in studies in individuals with NDDs, 
primarily ASD (Al-Zaid et al., 2015; de Bruin et al., 2009; Honekopp, 2012b; Manning et 
al., 2001), but the results in Study II did not find a significant relationship between the 
lower ratio and a diagnosis of ASD, similar to the findings in a recent large study of 
individuals with ASD versus TD by Guyatt et al. (2015) (Guyatt et al., 2015). However, 
weak relationships existed between lower ratios in individuals with diagnoses of any NDDs 
and in males with ADHD. 
 
Study III suggested specific morphological variants present in individuals with a 
duplication on Chromosome 12, which mirrored some of the same body areas affected by 
individuals previously identified with a deletion syndrome in that region (Adam, Mehta, 
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Knight, Hall, & Rossi, 2010; Carlsen, Frengen, Fannemel, & Misceo, 2015; Failla et al., 
2008; Weng, Luo, & Hou, 2018).   
 
When the examination of morphological variants was limited to the face only, as in Study 
VI, no association between the number of FMVs and a diagnosis of ASD, ADHD, or any 
NDD was present. Although previous studies have identified distinctive facial phenotypes 
in boys with ASD (Aldridge et al., 2011; Hammond et al., 2008; Obafemi-Ajayi et al., 
2015), as well as the possibility of more masculine and/or less feminine facial features in 
individuals with ASD (Bejerot et al., 2018; Tan et al., 2017), limiting the clinical 
assessment of an individual for morphological variants to the facial region alone failed to 
distinguish participants with NDDs from those with TD in study IV. Angkustsiri et al. 
(2011) compared in-person ratings of MPAs in photographs of faces and hands of 
individuals with ASD, developmental delay, and TD and also pointed out the limitations of 
assessments relying on just the face and hands in identifying morphological variants. 
However, their study found significantly higher rates of MPAs in individuals with ASD and 
developmental delay compared with those with TD.  
 
The overall results of the studies in this thesis find increased morphological variants 
descriptively in individuals with NDDs, but do not point to any distinct variants statistically 
that can be used in early diagnosis of NDDs. This supports the conclusion by Ozgen et al. 
(2010) that the number of morphological variants, rather than specific variants, may relate 
to NDD diagnoses. Using the total number of morphological variants versus identification 
of specific morphological variants in an individual may result in identifying someone with 
dysmorphism as defined by the work of Miles et al. (2005) and could be the more useful 
outcome of morphological assessments. The results of this thesis also point to the potential 
for the assessment of morphological variants to serve as a possible marker for individuals 
undergoing diagnosis of NDDs who may benefit from further assessment. Further 
assessment could include genetic testing to identify genetic variants as potential etiological 
mechanisms or eventually to use to subgroup individuals with NDDs that may benefit from 
certain types of treatments or interventions. However, further research is needed to examine 
the relationship between morphological variants and subgroups. 
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5.1.2 Strengths and Limitations of Studies 
5.1.2.1 Strengths  
The RATSS project for which the studies in this thesis are based includes many strengths, 
namely, that the RATSS explores multiple facets related to the development of NDDs, 
including the role of genetics and environment, biological process, and subsequent 
behavioral outcomes. The sample recruited in RATSS is based not only on a clinical 
sample, but also a population-based sample, thereby limiting selection bias and allowing for 
some ability to make statements for the broader population. The study involves deep 
phenotyping of participants through the use of standardized behavioral measures, biological 
specimen collection, and in-person assessments like physical examinations and MRI scans. 
The sample is almost equally balanced to include males and females, which has been a 
critique of previous research on NDDs using higher numbers of male participants based on 
the skewed sex ratio, especially in the area of ASD (Lai, Lombardo, Auyeung, Chakrabarti, 
& Baron-Cohen, 2015). Additionally, the sample includes dimensional, along with 
categorical, measures of NDD symptoms. Additional strengths pertaining directly to the 
methods used in the studies in this thesis are the use of multiple raters to determine 
interrater agreement in Studies I, II, and IV, the use of clinical geneticists who were experts 
in dysmorphology for in-person clinical assessments in Studies I, III, and IV, and the use of 
novel automated technology to assess morphological variants in Study IV in order to limit 
some of the subjective nature of assessments completed in-person.  
5.1.2.2 Limitations 
Limitations to the RATSS include that the sample in the study is from one country (i.e., 
Sweden) and was limited to recruitment of higher functioning participants with NDDs who 
could participate in the various procedures. This may have prevented some participants who 
may have been too severely impaired by their diagnoses to participate. Another limitation is 
examiner bias during in-person morphological assessments by clinical geneticists due to the 
inability to blind these examiners to the participants’ diagnoses as they met participants 
face-to-face. Limitations also exist in the checklist used to assess the morphological 
variants during the in-person clinical morphological assessments as it was not previously 
validated. The study also lacks parent photos or morphological assessments in parents to 
assess for familial tendency of morphological variants. The large number of radiologists 
who read the MRI scans of participants in the study over the years is a limitation because 
they may not have approached the scans in a consistent manner. Even though the RATSS 
sample includes many participants with NDDs, smaller sample sizes existed in the NDD 
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subgroups, which may have resulted in the inability to identify significant associations 
between diagnoses and variables of interest in the studies in this thesis. Finally, one could 
question the ability generalize the findings from the RATSS to the greater population, 
especially non-twins. It is important to note that the results of the studies in this thesis were 
consistent with the results of other cited studies conducted on singletons, thereby 
suggesting that being a twin may not place an individual at increased risk for either 
morphological variants or NDDs.  
5.1.3 Clinical Implications of Studies 
Clinical assessments for the presence of morphological variants may be able to aid in the 
identification of individuals who would benefit most from additional testing such as genetic 
testing when undergoing diagnosis of a NDD, especially if resources for additional testing 
are limited in a region or country. Recommendations exist within the US to conduct genetic 
testing on any child who receives a diagnosis of a NDD such as ASD and ID (Johnson et 
al., 2007; Moeschler et al., 2014; Schaefer et al., 2013; Volkmar et al., 2014), yet similar 
recommendations have not yet been made worldwide. Despite best practice 
recommendations for genetic testing, studies from the US show parents report around 35% 
of children with ASD actually receive genetic testing and less than 20% of parents report 
receiving information about genetic testing from their health care provider (Kiely, Vettam, 
& Adesman, 2016; Li et al., 2016). Genetic testing in the diagnosis of NDDs offers many 
benefits, including providing individuals with information about potential genetic causes, 
the ability of the information to guide some treatment decisions, providing families with 
information about recurrence risks of the NDD, as well as the possibility for early 
intervention related to detection of genetic conditions for which an individual may be at 
risk (Tammimies, Falck-Ytter, & Bölte, 2016; Tremblay et al., 2019; Vorstman et al., 
2017). Numerous constraints have been presented regarding universal genetic testing for 
children diagnosed with ASD (Tammimies et al., 2016; Tremblay et al., 2019; Vorstman et 
al., 2017), including parental reactions to testing (e.g., blame, guilt, anxiety) when inherited 
genetic variants are identified, potential to find conditions or risk for conditions related to 
poor prognosis or serious disease, lack of training of health care providers related to genetic 
testing and interpretation of test results, parent thoughts that the genetic testing will not lead 
to changes in the treatment decisions, and the cost and availability of testing worldwide.  
 
Although providing universal genetic testing offers benefits in terms of being able to 
expand the knowledge worldwide related to genetic variation in NDDs (Vorstman et al., 
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2017), a first step to encourage more genetic testing may be to include the use of a the 
clinical assessment for morphological variants to help determine the presence and number 
of MPAs or morphological variants that could then serve as a screening tool for individuals 
who may be at greater risk for an underlying genetic cause for the disorder and therefore, 
may most benefit from genetic testing. In fact, Tammimies et al. (2015) showed 37.5% of 
children classified as having “complex ASD” based on the presence of six or more MPAs, a 
structural brain abnormality, and/or major congenital anomalies were found to have a 
positive genetic finding through both CMA and WES genetic testing. Previous studies also 
point to higher MPA scores as suggestive of potential genetic reasons for the etiology of 
ASD that may be due to sporadic or non-familial reasons, including de novo genetic 
changes (Miles et al., 2005; Tammimies et al., 2015). It has been suggested recently that 
targeted screening of children believed to be at high-risk for ASD (e.g., presence of first-
degree relative with ASD, specific genetic conditions, etc.) may be a more efficient and 
cost-effective strategy than universal screening when it comes to early detection of NDDs 
(Yuen, Carter, Szatmari, & Ungar, 2018); thereby supporting the use of evaluations such as 
clinical assessments for morphological variants to identify children who may most benefit 
from early screening for NDDs. 
 
In summary, the clinical assessment may help classify children with NDDs for whom 
additional testing, such as further genetic or diagnostic testing, should be prioritized in 
order to better understand potential etiology for the disorders, as well as potential co-
morbidities or other factors that need to be considered in the evaluation and intervention 
related to the child undergoing NDD diagnosis.  
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6 CONCLUSION  
6.1 FUTURE DIRECTIONS 
Multiple avenues of research could be explored related to the outcomes so far in the studies 
in this thesis, as well as additional data collected through the RATSS project that could be 
analyzed in relationship to morphological variants. As previously noted, morphological 
variants, especially in the facial region, may mirror altered brain development due to 
simultaneous development in utero between the face and brain, which is guided by 
molecular signals (Jones, 2013; Marcucio et al., 2015). Comparing morphological variants 
(assessed either through clinical or automated assessments) with other measures utilized to 
evaluate children with NDDs, such as MRIs and genetic testing, may provide insight into 
the potential relationship between morphological variants, brain development, and genetics 
and would be a logical next study. Clinical or automated assessment of morphological 
variants may help identify children who could benefit from neuroimaging by exploring the 
relationship between morphological variants and the presence of abnormal MRIs. 
Currently, neuroimaging is not routinely recommended in the assessment of children for 
NDDs, like ASD (Filipek et al., 2000). Therefore, use of the clinical assessment may help 
prioritize children who would benefit most from neuroimaging in the diagnosis of NDDs. 
Additionally, a future study could explore the relationship between genetic variants 
identified through the genetic testing performed in RATSS (like presence and size of 
CNVs) with the presence of morphological variants, in line with previous studies which 
found increased morphological variants in individuals with genetic issues (e.g., Miles et al., 
2005; Tammimies et al., 2015).  
 
The RATSS collects prenatal and perinatal data from mothers of the twins. Since previous 
studies (Firestone & Prabhu, 1983; Links et al., 1980) have identified a relationship 
between increased MPAs and prenatal and perinatal complications, the effects of 
complications prenatally and perinatally in participants in RATSS could be explored in 
relation to the presence of morphological variants, especially those that differ within MZ 
pairs, as recommended by Links (1980).  
 
Since the in-person clinical assessment still remains the standard for identification of 
morphological variants, further studies exploring the use newer morphological measures 
like the Autism Dysmorphology Measure (Miles et al., 2008) in samples with not only 
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ASD, but also other NDDs which often overlap with ASD like ADHD and ID, may be 
warranted to see if the measure performs well in other samples from those in which it had 
been initially studied. Additionally, it would be important to explore the use of the Autism 
Dysmorphology Measure by a variety of variety of clinicians (e.g., nurses), and not just 
physicians, to determine if other providers can accurately use the measure to assess 
morphological variants. If the measure can be used by multiple types of providers, this 
would help increase the availability of these morphological assessments for individuals 
undergoing diagnosis of NDDs. Additionally, the area of physical examinations in NDDs 
could use the development of some standard guidelines worldwide so that any healthcare 
provider seeing an individual suspected of having a NDD would have a consistent and 
evidence-based approach to the examination so that all individuals would receive the 
recommended assessments, screenings, and associated next steps in a similar manner.  
 
Many of the participants in RATSS are recruited from CATSS, and in CATSS, a measure 
called the Dysmorphic Concern Questionnaire (DCQ) (Oosthuizen, Lambert, & Castle, 
1998) is administered to participants at 18 years of age. The self-administered questionnaire 
consists of seven questions that assess for concerns an individual may have related to 
dysmorphic appearance. In CATSS, an additional question is included related to the 
whether a disease or some type of damage to one’s appearance has caused an individual to 
worry about their appearance. The original study regarding the development and validation 
of the DCQ questionnaire was conducted on 90 patients with varying psychiatric disorders 
admitted to a psychiatric ward, including over half with schizophrenia and nearly 40% with 
affective disorders (Oosthuizen et al., 1998). The study did not find a relationship between 
increasing scores on the DCQ (indicating greater dysmorphic concerns) and ratings of 
dysmorphology using the Waldrop scale. However, it is important to note that this sample 
was small and included adults already admitted to a psychiatric ward and not a population-
based sample. Therefore, a future possible study could match the same participants in 
RATSS with those in CATSS who have turned 18 years to compare in-person clinical or 
automated assessments of morphological variants in RATSS to self-rated dysmorphology in 
CATSS using the DCQ.  
6.2 CONCLUSION  
The studies in this thesis aim to identify characteristics of morphological variants that can 
support NDD screening and risk assessment, to test whether it is possible to obtain reliable 
morphological assessments using low-cost automated technology, and to utilize the twin 
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design to explore the potential genetic and environmental influences on the development of 
morphological variants. The studies in this thesis found no distinct morphological variants 
to distinguish those with NDDs from those with TD, but increasing numbers of 
morphological variants may be a marker to identify individuals who would benefit from 
further assessments, such as genetic testing, which is not currently routinely recommended 
in the diagnosis of individuals with NDDs. Although automated methods of assessment for 
morphological variants demonstrated high to complete agreement with in-person clinical 
assessments, the technology in this area is still emerging and is currently limited to only 
particular body regions (e.g., face). Consequently, this technology may miss morphological 
variants present in other areas of the body that may help determine appropriate next steps 
for an individual suspected of having an NDD. Further research is needed on the use of 
these automated technologies to identify morphological variants, as well as the expansion 
of these technologies to assess morphological variants in the entire habitus. Finally, as 
expected, MPAs were found to be highly correlated in MZ compared with DZ twins, 
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Appendix 1. Morphological variants assessed in-person and translated from Swedish to English and then into HPO terms and aligned with items 
assessed with Face2Gene. 
 
Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Panna  Forehead     
Panna hög High forehead High forehead (348)   
Panna låg Low forehead Low hairline (294)   
Panna buktande Bulging forehead Prominent Forehead (11220)   
Panna sluttande Sloping forehead Sloping forehead (340)   
Panna bred Broad forehead Broad forehead (337)   
Panna smal Narrow forehead Narrow forehead (341) Narrow forehead 
Tinningar insjunkna Sunken temples   Narrow forehead 
        
Hår eller hårfäste avvikande Hair or Hairline     
Hårfäste högt i nacke och panna High anterior and posterior hairline High posterior hairline (12891) and High 
anterior hairline (9890) 
High anterior hairline 
Hårfäste lågt i nacke och panna Low anterior and posterior hairline Low anterior hairline (294) Low posterior 
hairline (2162) 
  
Hårfäste treflikigt Three-peak hairline Pointed frontal hairline (4544)   
Cows lick Cowlick     
Widows peak Widow's Peak Widow's peak (349)   
Hår tjockt Thick hair Thick hair (100874)   
Hår tunt Thin hair Fine hair (2213) or Sparse scalp hair (2209) Sparse scalp hair 
Hår strävt Rough hair Coarse hair (2280)   
Hår ljust Bright hair Fair hair (2286)   
Hår mörkt Dark hair     
Hår lockigt Curly hair Curly hair (2210)   
Hår rakt Straight hair     
Hår pigmentförändringar Pigment anomalies in hair Abnormality of hair pigmentation (9887)   
Hirsutism Hirsutism Hirsutism (1007)   
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Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Ögonbryn/fransar avvikande Eyebrow or Eyelashes     
Ögonfransar långa Long eyelashes Long eyelashes (527)   
Ögonfransar korta Short eyelashes Short eyelashes (10764)   
Ögonfransar saknas Absent eyelashes Sparse or absent eyelashes (200102)   
Ögonfransar dubbla Double eyelashes Multiple rows of eyelashes (8496)   
Ögonbryn högt placerade High placed eyebrow Abnormal location of eyebrow (40296)   
Ögonbryn lågt placerade Low placed eyebrow Abnormal location of eyebrow (40296)   
Ögonbryn raka Straight or horizontal eyebrow Horizontal eyebrow (11228)   
Ögonbryn bågformade Highly arched eyebrow Highly arched eyebrow (2553) Highly arched eyebrow 
Ögonbryn outvecklade lateralt Underdeveloped eyebrow- laterally Sparse lateral eyebrow (5338) or sparse 
eyebrow (45075) 
Sparse eyebrow 
Ögonbryn outvecklade medialt Underdeveloped eyebrow- medially Sparse medial eyebrow (25325) or sparse 
eyebrow (45075), Medial flaring of the 
eyebrow (10747) 
Sparse eyebrow, Medial 
flaring of the eyebrow 
Ögonbryn saknas Missing eyebrow Absent Eyebrow (2223)   
Synofrys Synophrys Synophrys (664) Synophrys 
        
Hud avvikande Skin     
Hud tjock Thick skin Thickened skin (1072)   
Hud tunn Thin skin Thin skin (963)   
Hud ljus Light skin Hypopigmentation of the skin (1010)   
Hud mörk Dark skin Hyperpigmentation of the skin (953)   
Hud torr Dry skin Dry skin (958)   
Hud fet  Oily skin     
Hud sammetslen Velvety skin Soft skin (977)   
Hud åldrad Aged skin Excessive wrinkled skin (7392)   
Hud överskott Excess skin Redundant skin (1582)   
Hud stram  Tight skin Stiff skin (30053)   
Hud onormal fettdistribution Abnormal fat distribution     
Café au lait-fläckar Café au lait spots Cafe au lait spots (957)   
Hypopigmenteringar Hypopigmentation Hypopigmented skin patches (1053)    
Nevi Nevi Hyperpigmented nevi (7481)   
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Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Hemangiom Hemangioma Hemangioma (1028)   
Tumörer Tumor Neoplasm of the skin (8069)   
Blåsor Blisters Skin vesicle (200037)   
Papler Papules Skin-colored papule (25512)   
        
Ansiktform avvikande  Facial Form     
Ansiktsform runt Round face Round face (311)   
Ansiktsform fyrkantigt Square face Square face (321)   
Ansiktsform triangelformat Triangular face Triangular face (325) Triangular face 
        
Nacke avvikande Neck     
Nacke bred Broad neck Broad neck (475)   
Nacke kort Short neck Short neck (470)   
Nacke ökat nackskinn Redundant nuchal skin Redundant neck skin (5989)   
Nacke pterygium Neck webbing Webbed neck (465)   
        
Ögon avvikande Eyes     
Synavvikelse  Visual Impairment Abnormality of vision (504)   
Ögonen små Microphtalmia Micophtalmia (568)   
Ögonglob saknas Missing eyeballs or Anophthalmia Anophthalmia (528)   
Iris avvikelser Iris abnormalities Aplasia/Hypoplasia of the iris (8053), 
Abnormality of the iris (525) Abnormal iris 
pigmentation (8034), Iris hypopigmentation 
(7730), Asymmetry of iris pigmentation 
(200064) 
  
Ögonen prominenta Prominent eyes Large eyes (1090) or Propotosis (520) Propotosis 
Ögonen djupt liggande  Deeply set eyes Deeply set eye (490)   
Hypertelorism Hypertelorism Hypertelorism (316) Hypertelorism 
Hypotelorism Hypotelorism Hypotelorism (601) Hypotelorism 
Ögonspringor korta  Short palpebral fissure Short palpebral fissure (12745), 
Blepharophimosis (581) 
Blepharophimosis 
Ögonspringor långa Long palpebral fissure Long palpebral fissure (637)   
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Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Ögonspringor nedåtsluttande Downslanted palpebral fissure Downslanted palpebral fissure (494) Downslanted palpebral 
fissures 
Ögonspringor uppåtsluttande Upslanted palpebral fissure Upslanted palpebral fissure (582) Upslanted palpebral fissure 
        
Epikantus Epicanthus Epicanthus (286) Epicanthus 
Telekantus Telecanthus (506) Telecanthus Telecanthus 
Ptos Ptosis Ptosis (508) Ptosis 
Kolobom Coloboma Coloboma (589)   
Telangiektasier Telangiectasias Conjunctival telangiectasia (524)   
Avvikande tårproduktion Abnormal tear production     
Ögonbottenundersökning avvikande Abnormality in retina Abnormal retinal morphology (479)   
Linsdislokation Lens dislocation     
Näthinneavlossning Retinal detachment Retinal detachment (541)   
Glaukom Glaucoma Glaucoma (501)   
Katarakt Cataract Cataract (518)   
        
Munregion avvikande Mouth Region     
Mun stor Wide mouth Wide mouth (154)   
Mun liten Narrow mouth Narrow mouth (160)   
Överläppen tältformad Tented upper lip Tented upper lip vermillion (10804), Tented 
philtrum (11825) 
Tented upper lip vermillion, 
Tented philtrum 
Läpparna tjocka  Thick lip Thick lower lip vermilion (179), Thick upper 
lip vermilion (215) 
Thick upper lip vermilion, 
Thick lower lip vermilion 
Läpparna smala Thin lip Thin upper lip vermilion (419) Thin lower lip 
vermilion (10282) 
Thin upper lip vermilion 
Läppspalt  Cleft lip Cleft lip (410030)   
Andra avvikelser, t.ex. gropar, 
upphöjningar eller avvikelser av 
frenulum 
Other anomalies- e.g., dimples, ridges, 
or deviations of frenulum 
    
Gom hög High palate High palate (218)   
Gom spetsig Angled palate High palate (218)   
Uvula bred Broad uvula Broad uvula (10809)   
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Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Uvula bifid Bifid or cleft uvula Bifid uvula (193)   
Gingiva tjock Thick gingiva Gingival overgrowth (212)   
Tunga stor Large tongue Protruding tongue (10808)   
Tunga grov Furrowed tongue Furrowed tongue (221)   
Tunga missbildad Malformed tongue     
Mikrognati Micrognathia Micrognathia (347), Retrognathia (278), 
Abnormality of the chin (306) 
Abnormality of the chin 
Prognati Prognathia Mandibular prognathia (303), Abnormality of 
the chin (306) 
Abnormality of the chin 
        
        
Filtrum avvikande Philtrum     
Filtrum långt Long philtrum Long philtrum (343) Long philtrum 
Filtrum kort  Short philtrum Short philtrum (322) Short philtrum 
Filtrum utslätat Smooth philtrum Smooth philtrum (319) Smooth philtrum 
Filtrum djupt  Deep philtrum Deep philtrum (2002) Deep philtrum 
        
Tänder avvikande Teeth     
Bett trångt Dental crowding Dental crowding (678)   
Bett brett Widely spaced teeth Widely spaced teeth (687)   
Tänder glesa Oligodontia Oligodontia (677)   
Tänder stora Macrodontia Macrodontia (1572)   
Tänder små Microdontia Microdontia (691)   
Avvikande tandform Abnormal tooth shape Abnormality of dental morphology (6482)   
Emaljdefekter Enamel defect Abnormality of dental enamel (682)   
Hypodonti Hypodontia Hypodontia (668)   
Adonti Anodontia Anodontia (674)   
Extra tänder Additional teeth Abnormal number of teeth (6483)   
Onormal tid för tanderuption Delayed or advanced eruption Delayed eruption of teeth (684) or advanced 
eruption of teeth (6288) 
  
Andra tandavvikelser Other dental abnormalities     
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Checklist (Swedish) Checklist (English) HPO Feature Term and ID Face2Gene Item 
Öron avvikande Ears     
Små Microtia Microtia (8851)   
Stora Long ear Long ear (400004)   
Dysplastiska Dysplastic ears Abnormality of outer ear (356)   
Lågt sittande Low-set ear Low-set ears (369) Low-set ears 
Bakåtroterade Posteriorly rotated ear Posteriorly rotated ear (358)   
Helices nervikta Overfolded helix Overfolded helix (396) Overfolded helix 
Helices tjocka Thick helices Prominent ear helix (9004)   
Helices tunna Thin helices Thin ear helix (9005)   
Örsnibben avvikande form Abnormal earlobe form Abnormality of earlobe   
Preaurikulära bihang, gropar/fåror  Preauricular tags or pits Preauricular pit (4467), Periauricular skin pits 
(100277), Preauricular skin tag (384) 
  
        
Näsa avvikande Nose     
Näsa liten Small nose Slender Nose (417)   
Näsa stor Prominent Nose Prominent nose (448)   
Näsa lång Long nose Long nose (3189)   
Näsa kort Short nose Short nose (3196) Short nose 
Näsa platt Flat nose Depressed nasal tip (437)   
Näsa nedåtböjd Hooked nose Nose, hooked (9000066)   
Näsa uppåtböjd Upturned tip of the nose Abnormality of the nasal tip (436) Abnormality of the nasal tip 
Näsrygg hög High nasal bridge Prominent nasal bridge (426) Prominent nasal bridge 
Näsrygg låg Low nasal bridge Short nasal bridge (3194)   
Näsrygg bred Broad nasal bridge Wide nasal bridge (431) Wide nasal bridge 
Näsrygg smal Thin nasal bridge Narrow nasal bridge (446)   
Nästipp bred Broad nasal tip Broad nasal tip (455) Broad nasal tip 
Nästipp smal Narrow nasal tip Narrow nasal tip (11832)   
Nässkiljevägg kort Short columella Short columella (2000)   
Nässkiljevägg slutar den nedanför 
näsvingen 
Low hanging columella Low hanging columella (9765)   
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Näsvingar små Narrow naris Narrow naris (9933), Underdeveloped nasal 
alae (430) 
Underdeveloped nasal alae 
Näsvingar anteverterade Anteverted nares Anteverted nares (463) Anteverted nares 
 
  
